query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_0914_ESMFold_hypothetical_protein	6zxh-assembly1.cif.gz_z	LOKIASV2_0914_ESMFold_hypothetical_protein	6zxh-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State H2	0.233	273	199	40	312	39	299	1.659E-15	437
LOKIASV2_0914_ESMFold_hypothetical_protein	1zar-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zar-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ADP and Manganese Ions	0.208	225	147	43	267	80	266	2.294E-13	418
LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly2.cif.gz_B Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.197	265	187	4	268	7	240	2.870E-13	415
LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.196	265	191	4	268	7	244	2.870E-13	411
LOKIASV2_0914_ESMFold_hypothetical_protein	3re4-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3re4-assembly2.cif.gz_B Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	0.200	263	191	4	266	7	246	1.550E-13	411
LOKIASV2_0914_ESMFold_hypothetical_protein	3re4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3re4-assembly1.cif.gz_A Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase bound to Toyocamycin.	0.193	265	197	4	268	7	251	3.036E-13	411
LOKIASV2_0914_ESMFold_hypothetical_protein	6zxf-assembly1.cif.gz_z	LOKIASV2_0914_ESMFold_hypothetical_protein	6zxf-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State G	0.215	260	203	40	299	39	297	3.230E-14	407
LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly3.cif.gz_C Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.198	268	188	1	268	6	240	5.945E-13	400
LOKIASV2_0914_ESMFold_hypothetical_protein	1zao-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zao-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio2 Kinase Complexed With ATP and Manganese Ions	0.200	226	151	43	268	81	270	1.302E-12	397
LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	1zth-assembly4.cif.gz_D Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.200	266	189	1	266	6	242	5.315E-13	396
LOKIASV2_0914_ESMFold_hypothetical_protein	6zv6-assembly1.cif.gz_h	LOKIASV2_0914_ESMFold_hypothetical_protein	6zv6-assembly1.cif.gz_h Human RIO1(kd)-StHA late pre-40S particle, structural state B (post 18S rRNA cleavage)	0.230	250	162	40	289	4	215	1.231E-12	387
LOKIASV2_0914_ESMFold_hypothetical_protein	1ztf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1ztf-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase	0.206	244	189	23	266	13	251	2.039E-12	379
LOKIASV2_0914_ESMFold_hypothetical_protein	4otp-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4otp-assembly1.cif.gz_A Crystal structure of the catalytic domain of the human RioK1 atypical protein kinase in complex with ADP/Mg2+	0.228	270	173	40	309	4	228	5.315E-13	375
LOKIASV2_0914_ESMFold_hypothetical_protein	6zxd-assembly1.cif.gz_z	LOKIASV2_0914_ESMFold_hypothetical_protein	6zxd-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F1	0.234	270	187	46	315	36	280	6.690E-14	374
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_B Rio2 structure	0.225	216	136	43	258	68	244	1.812E-11	356
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_D Human Rio2 kinase structure	0.208	231	166	39	269	69	278	5.587E-12	354
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_B Human Rio2 kinase structure	0.208	227	162	43	269	71	275	1.224E-11	346
LOKIASV2_0914_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_B Crystal structure of RIOK2 in complex with CQ211	0.212	225	159	45	269	79	281	1.035E-11	344
LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly2.cif.gz_F	LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly2.cif.gz_F Human RIOK2 bound to inhibitor	0.231	214	143	45	258	84	270	3.752E-11	343
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly2.cif.gz_C Human Rio2 kinase structure	0.216	241	162	43	283	77	284	9.250E-12	341
LOKIASV2_0914_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7vbt-assembly1.cif.gz_A Crystal structure of RIOK2 in complex with CQ211	0.210	244	169	43	286	81	295	6.991E-12	339
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdn-assembly1.cif.gz_A Rio2 structure	0.208	237	166	22	258	15	224	2.026E-11	338
LOKIASV2_0914_ESMFold_hypothetical_protein	6zxe-assembly1.cif.gz_z	LOKIASV2_0914_ESMFold_hypothetical_protein	6zxe-assembly1.cif.gz_z Cryo-EM structure of a late human pre-40S ribosomal subunit - State F2	0.225	271	202	40	310	4	264	4.493E-13	335
LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly5.cif.gz_H	LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly5.cif.gz_H Human RIOK2 bound to inhibitor	0.233	216	138	43	258	82	262	1.088E-10	335
LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly3.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly3.cif.gz_E Human RIOK2 bound to inhibitor	0.227	214	143	45	258	85	270	7.772E-11	334
LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_G	LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_G Human RIOK2 bound to inhibitor	0.226	214	136	45	258	76	252	1.610E-10	333
LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_J	LOKIASV2_0914_ESMFold_hypothetical_protein	6hk6-assembly4.cif.gz_J Human RIOK2 bound to inhibitor	0.231	214	143	45	258	85	271	9.724E-11	333
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdm-assembly1.cif.gz_A Human Rio2 kinase structure	0.213	231	164	39	269	73	282	4.197E-11	331
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdo-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdo-assembly1.cif.gz_A Rio2 structure	0.217	241	165	45	285	75	286	1.369E-11	329
LOKIASV2_0914_ESMFold_hypothetical_protein	6fdo-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6fdo-assembly2.cif.gz_B Rio2 structure	0.218	227	163	43	269	72	280	3.355E-11	327
LOKIASV2_0914_ESMFold_hypothetical_protein	6g51-assembly1.cif.gz_v	LOKIASV2_0914_ESMFold_hypothetical_protein	6g51-assembly1.cif.gz_v Cryo-EM structure of a late human pre-40S ribosomal subunit - State D	0.190	275	198	43	317	76	320	5.251E-11	282
LOKIASV2_0914_ESMFold_hypothetical_protein	4gyi-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4gyi-assembly1.cif.gz_A Crystal structure of the Rio2 kinase-ADP/Mg2+-phosphoaspartate complex from Chaetomium thermophilum	0.185	264	205	43	306	84	336	6.530E-10	271
LOKIASV2_0914_ESMFold_hypothetical_protein	6fai-assembly1.cif.gz_l	LOKIASV2_0914_ESMFold_hypothetical_protein	6fai-assembly1.cif.gz_l Structure of a eukaryotic cytoplasmic pre-40S ribosomal subunit	0.180	222	165	43	264	83	284	6.137E-09	259
LOKIASV2_0914_ESMFold_hypothetical_protein	7wu0-assembly1.cif.gz_v	LOKIASV2_0914_ESMFold_hypothetical_protein	7wu0-assembly1.cif.gz_v Cryo-EM structure of a human pre-40S ribosomal subunit - State RRP12-B3	0.202	274	193	43	316	76	318	1.431E-09	244
LOKIASV2_0914_ESMFold_hypothetical_protein	4gyg-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4gyg-assembly1.cif.gz_A Crystal structure of the Rio2 kinase from Chaetomium thermophilum	0.184	292	220	37	306	38	329	1.022E-09	244
LOKIASV2_0914_ESMFold_hypothetical_protein	7szc-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7szc-assembly2.cif.gz_C Crystal Structure Analysis of human PRPK complex with a compound	0.128	241	187	43	283	6	221	4.359E-08	231
LOKIASV2_0914_ESMFold_hypothetical_protein	7szc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7szc-assembly1.cif.gz_A Crystal Structure Analysis of human PRPK complex with a compound	0.134	247	194	37	283	3	227	6.823E-08	216
LOKIASV2_0914_ESMFold_hypothetical_protein	6eml-assembly1.cif.gz_r	LOKIASV2_0914_ESMFold_hypothetical_protein	6eml-assembly1.cif.gz_r Cryo-EM structure of a late pre-40S ribosomal subunit from Saccharomyces cerevisiae	0.190	215	149	43	257	80	264	8.974E-07	208
LOKIASV2_0914_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_B Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.176	217	172	51	267	4	213	6.413E-07	168
LOKIASV2_0914_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.170	217	175	51	267	8	219	7.586E-07	168
LOKIASV2_0914_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	0.127	217	185	51	267	4	216	1.966E-06	149
LOKIASV2_0914_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C Crystal Structure of DYRK1A with small molecule inhibitor	0.115	194	165	55	241	26	219	4.555E-06	149
LOKIASV2_0914_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	0.122	217	189	50	266	5	220	2.751E-06	148
LOKIASV2_0914_ESMFold_hypothetical_protein	7a52-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7a52-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 6	0.133	195	161	55	241	19	213	1.966E-06	148
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2t-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	0.148	239	201	45	283	3	239	5.421E-07	147
LOKIASV2_0914_ESMFold_hypothetical_protein	5maf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5maf-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.176	239	189	45	283	2	231	2.460E-06	145
LOKIASV2_0914_ESMFold_hypothetical_protein	6s1i-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6s1i-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	0.122	195	163	55	241	26	220	7.975E-06	145
LOKIASV2_0914_ESMFold_hypothetical_protein	8c01-assembly1.cif.gz_r	LOKIASV2_0914_ESMFold_hypothetical_protein	8c01-assembly1.cif.gz_r Enp1TAP_A population of yeast small ribosomal subunit precursors	0.175	243	166	13	255	4	205	3.421E-05	144
LOKIASV2_0914_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.156	229	181	55	283	3	218	1.758E-06	144
LOKIASV2_0914_ESMFold_hypothetical_protein	4un0-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4un0-assembly2.cif.gz_D Crystal structure of the human CDK12-cyclinK complex	0.136	271	196	52	279	4	274	2.212E-07	144
LOKIASV2_0914_ESMFold_hypothetical_protein	5tvt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5tvt-assembly1.cif.gz_A Structure of Maternal Embryonic Leucine Zipper Kinase	0.156	243	198	41	283	2	237	1.758E-06	144
LOKIASV2_0914_ESMFold_hypothetical_protein	2zv9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2zv9-assembly1.cif.gz_A Lyn Tyrosine Kinase Domain-PP2 complex	0.115	243	198	55	279	11	253	4.333E-07	143
LOKIASV2_0914_ESMFold_hypothetical_protein	5mah-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5mah-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.162	239	191	45	283	4	232	4.817E-06	143
LOKIASV2_0914_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_B Structure of RIP2K(D146N) with bound Staurosporine	0.131	264	218	51	302	12	275	1.859E-06	142
LOKIASV2_0914_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B Structure of RIP2K(L294F) with bound AMPPCP	0.139	232	193	50	274	11	242	1.248E-05	142
LOKIASV2_0914_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	0.176	235	184	49	283	4	227	3.640E-06	142
LOKIASV2_0914_ESMFold_hypothetical_protein	8sam-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.140	283	240	11	293	204	483	8.974E-07	142
LOKIASV2_0914_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.139	215	177	59	273	16	222	2.199E-06	141
LOKIASV2_0914_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 1	0.139	265	218	55	308	7	271	4.097E-07	140
LOKIASV2_0914_ESMFold_hypothetical_protein	7a53-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7a53-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 7	0.124	195	163	55	241	19	213	5.698E-06	140
LOKIASV2_0914_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	0.141	257	191	45	301	4	226	2.079E-06	139
LOKIASV2_0914_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.124	259	219	55	305	11	269	2.910E-06	138
LOKIASV2_0914_ESMFold_hypothetical_protein	7z5n-assembly7.cif.gz_G	LOKIASV2_0914_ESMFold_hypothetical_protein	7z5n-assembly7.cif.gz_G Crystal structure of DYRK1A in complex with CX-4945	0.138	191	160	55	241	24	214	8.920E-06	138
LOKIASV2_0914_ESMFold_hypothetical_protein	6uip-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6uip-assembly2.cif.gz_B DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	0.135	193	161	55	241	25	217	7.975E-06	138
LOKIASV2_0914_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.141	225	184	59	283	16	230	3.640E-06	137
LOKIASV2_0914_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	0.122	212	185	55	266	9	220	7.130E-06	137
LOKIASV2_0914_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	0.116	251	218	55	302	10	260	8.023E-07	137
LOKIASV2_0914_ESMFold_hypothetical_protein	7nj0-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7nj0-assembly1.cif.gz_B CryoEM structure of the human Separase-Cdk1-cyclin B1-Cks1 complex	0.164	189	152	59	241	9	197	1.055E-05	137
LOKIASV2_0914_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.125	227	193	50	276	8	228	1.180E-05	136
LOKIASV2_0914_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.156	229	182	55	283	4	220	4.555E-06	136
LOKIASV2_0914_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.145	238	198	51	288	4	236	3.255E-06	136
LOKIASV2_0914_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	0.142	192	160	55	241	25	216	9.977E-06	136
LOKIASV2_0914_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A	0.122	193	167	55	245	26	218	1.180E-05	136
LOKIASV2_0914_ESMFold_hypothetical_protein	8sam-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.138	277	218	40	293	206	482	3.442E-06	136
LOKIASV2_0914_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.156	229	183	55	283	4	221	4.817E-06	135
LOKIASV2_0914_ESMFold_hypothetical_protein	5xy1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5xy1-assembly1.cif.gz_A Crystal structure of Lyn kinase domain in complex with N-(1H-indazol-6-yl)-8-(piperidin-4-yloxy)-6-propylquinazolin-2-amine	0.109	247	215	55	301	11	252	2.199E-06	134
LOKIASV2_0914_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E Crystal structure of DYRK1A in complex with CX-4945	0.139	195	160	55	241	26	220	1.747E-05	134
LOKIASV2_0914_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.129	243	193	55	277	9	251	1.320E-05	133
LOKIASV2_0914_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	0.114	255	198	55	278	16	270	4.817E-06	133
LOKIASV2_0914_ESMFold_hypothetical_protein	2pk9-assembly3.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2pk9-assembly3.cif.gz_A Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway	0.143	188	160	55	242	2	189	4.307E-06	133
LOKIASV2_0914_ESMFold_hypothetical_protein	6ln1-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6ln1-assembly2.cif.gz_B A natural inhibitor of DYRK1A for treatment of diabetes mellitus	0.127	194	166	55	245	21	214	7.130E-06	133
LOKIASV2_0914_ESMFold_hypothetical_protein	7akb-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7akb-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 56	0.123	234	200	55	283	19	252	5.095E-06	133
LOKIASV2_0914_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.093	219	197	50	268	4	221	1.396E-05	132
LOKIASV2_0914_ESMFold_hypothetical_protein	4bl1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bl1-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with AMP-PNP	0.141	238	188	43	280	2	221	6.027E-06	132
LOKIASV2_0914_ESMFold_hypothetical_protein	8sap-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	0.140	272	218	40	293	194	465	1.562E-05	132
LOKIASV2_0914_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_A Structure of RIP2K(D146N) with bound Staurosporine	0.113	263	210	51	288	12	274	5.388E-06	131
LOKIASV2_0914_ESMFold_hypothetical_protein	7ajy-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7ajy-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 51	0.135	230	197	55	283	18	247	3.640E-06	131
LOKIASV2_0914_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 25	0.133	234	198	55	283	13	246	4.555E-06	131
LOKIASV2_0914_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.104	235	202	55	281	6	240	3.059E-05	130
LOKIASV2_0914_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	0.130	234	197	55	281	9	242	1.180E-05	130
LOKIASV2_0914_ESMFold_hypothetical_protein	5vdk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5vdk-assembly1.cif.gz_A Crystal structure of human WEE2 kinase domain in complex with MK1775	0.109	219	190	50	268	6	219	7.086E-05	130
LOKIASV2_0914_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	0.132	276	222	51	307	4	279	9.491E-07	130
LOKIASV2_0914_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	0.149	270	209	51	297	5	274	3.255E-06	130
LOKIASV2_0914_ESMFold_hypothetical_protein	3cok-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3cok-assembly2.cif.gz_B Crystal structure of PLK4 kinase	0.133	220	177	55	274	14	218	3.827E-05	129
LOKIASV2_0914_ESMFold_hypothetical_protein	4xli-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4xli-assembly1.cif.gz_A Crystal structure of Abl2/Arg kinase in complex with dasatinib	0.134	253	215	55	303	11	263	7.540E-06	129
LOKIASV2_0914_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A Intracellular Ser/Thr protein kinase domain of Mycobacterium tuberculosis PknB.	0.127	247	198	50	277	6	252	9.977E-06	129
LOKIASV2_0914_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.114	262	217	56	301	15	276	4.072E-06	129
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.141	232	197	49	280	6	235	1.396E-05	129
LOKIASV2_0914_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.141	216	180	52	267	14	223	1.320E-05	129
LOKIASV2_0914_ESMFold_hypothetical_protein	3uzs-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3uzs-assembly1.cif.gz_A Structure of the C13.28 RNA Aptamer Bound to the G Protein-Coupled Receptor Kinase 2-Heterotrimeric G Protein Beta 1 and Gamma 2 Subunit Complex	0.149	165	129	55	219	164	316	1.552E-04	129
LOKIASV2_0914_ESMFold_hypothetical_protein	4o0w-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4o0w-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.125	236	194	55	277	10	245	1.954E-05	128
LOKIASV2_0914_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	0.119	252	196	55	278	16	267	8.434E-06	128
LOKIASV2_0914_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	0.150	267	217	55	310	15	281	6.027E-06	128
LOKIASV2_0914_ESMFold_hypothetical_protein	7a4s-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7a4s-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 2	0.144	195	159	55	241	12	206	1.248E-05	128
LOKIASV2_0914_ESMFold_hypothetical_protein	3w55-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3w55-assembly1.cif.gz_A The structure of ERK2 in complex with FR148083	0.155	218	172	52	269	14	217	6.374E-06	128
LOKIASV2_0914_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.136	240	202	55	289	26	265	5.095E-06	128
LOKIASV2_0914_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7mu7-assembly1.cif.gz_A Ask1 bound to compound 3	0.148	233	182	59	291	15	229	8.920E-06	127
LOKIASV2_0914_ESMFold_hypothetical_protein	7up4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7up4-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.112	262	221	55	304	10	271	9.434E-06	127
LOKIASV2_0914_ESMFold_hypothetical_protein	3lm5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3lm5-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B) in complex with Quercetin	0.135	240	198	47	286	8	237	1.055E-05	127
LOKIASV2_0914_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	0.130	232	198	55	283	20	251	6.741E-06	127
LOKIASV2_0914_ESMFold_hypothetical_protein	6ln1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6ln1-assembly1.cif.gz_A A natural inhibitor of DYRK1A for treatment of diabetes mellitus	0.126	214	185	55	267	26	239	1.116E-05	127
LOKIASV2_0914_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.121	240	199	55	281	4	243	1.562E-05	126
LOKIASV2_0914_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.114	233	198	56	280	6	238	3.059E-05	126
LOKIASV2_0914_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2 THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION	0.125	266	202	55	286	7	272	2.892E-05	126
LOKIASV2_0914_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES	0.131	266	201	55	286	10	275	1.747E-05	126
LOKIASV2_0914_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	LOKIASV2_0914_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	0.150	213	176	55	267	4	211	1.116E-05	126
LOKIASV2_0914_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A Crystal structure of pseudokinase CASK in complex with PFE-PKIS12	0.132	294	224	50	308	5	298	8.920E-06	126
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	0.160	242	192	42	283	2	230	8.920E-06	126
LOKIASV2_0914_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 22	0.117	213	178	55	267	39	241	4.047E-05	126
LOKIASV2_0914_ESMFold_hypothetical_protein	7ak2-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7ak2-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 53	0.127	195	162	55	241	19	213	1.848E-05	126
LOKIASV2_0914_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	0.138	258	219	50	307	6	260	1.747E-05	125
LOKIASV2_0914_ESMFold_hypothetical_protein	5lvp-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.134	224	187	51	274	7	223	1.477E-05	125
LOKIASV2_0914_ESMFold_hypothetical_protein	5ih9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ih9-assembly1.cif.gz_A MELK in complex with NVS-MELK8A	0.138	239	195	45	283	4	230	4.555E-06	125
LOKIASV2_0914_ESMFold_hypothetical_protein	6eif-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6eif-assembly4.cif.gz_D DYRK1A in complex with XMD7-117	0.123	195	163	55	241	27	221	1.848E-05	125
LOKIASV2_0914_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	0.127	234	199	55	283	30	263	7.975E-06	125
LOKIASV2_0914_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	0.120	248	203	56	287	17	264	1.562E-05	125
LOKIASV2_0914_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.127	245	201	56	286	17	261	2.445E-05	125
LOKIASV2_0914_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	0.095	214	193	55	268	3	216	2.312E-05	125
LOKIASV2_0914_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.109	237	209	59	294	17	253	7.540E-06	124
LOKIASV2_0914_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	0.134	272	215	51	299	15	286	4.817E-06	124
LOKIASV2_0914_ESMFold_hypothetical_protein	3kn5-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3kn5-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of msk1 in complex with AMP-PNP	0.111	272	223	59	310	17	288	6.027E-06	124
LOKIASV2_0914_ESMFold_hypothetical_protein	5a3x-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5a3x-assembly3.cif.gz_C DYRK1A in complex with hydroxy benzothiazole fragment	0.125	234	200	55	283	27	260	1.116E-05	124
LOKIASV2_0914_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y/V116I with hematein	0.120	254	196	55	278	39	292	1.180E-05	124
LOKIASV2_0914_ESMFold_hypothetical_protein	5he0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5he0-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG215022	0.107	307	242	27	298	130	436	6.027E-06	124
LOKIASV2_0914_ESMFold_hypothetical_protein	4bi1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bi1-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.138	225	186	55	279	11	227	1.116E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	8s9f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8s9f-assembly1.cif.gz_A Crystal structure of the kinase domain of Bruton's Tyrosine Kinase bound to dasatinib	0.145	246	199	56	301	13	246	1.848E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	6d3k-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6d3k-assembly1.cif.gz_A Crystal structure of unphosphorylated human PKR kinase domain in complex with ADP	0.125	248	205	50	284	9	256	7.130E-06	123
LOKIASV2_0914_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C DYRK1A in complex with methoxy benzothiazole fragment	0.151	229	194	55	283	27	255	3.421E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	7up7-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7up7-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.110	271	226	55	309	9	279	7.130E-06	123
LOKIASV2_0914_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	0.134	224	191	51	274	8	228	1.116E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	0.140	262	219	55	310	16	277	1.180E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	0.127	251	206	55	291	7	257	4.307E-06	123
LOKIASV2_0914_ESMFold_hypothetical_protein	4fv9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fv9-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E71	0.142	253	214	52	301	17	269	4.817E-06	123
LOKIASV2_0914_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	0.126	234	199	55	283	28	261	1.180E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	6eij-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6eij-assembly3.cif.gz_C DYRK1A in complex with HG-8-60-1	0.140	195	160	55	241	26	220	6.700E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	7o7k-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7o7k-assembly1.cif.gz_A Crystal structure of the human DYRK1A kinase domain bound to abemaciclib	0.123	195	163	55	241	27	221	3.827E-05	123
LOKIASV2_0914_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.128	312	255	7	299	26	337	4.555E-06	123
LOKIASV2_0914_ESMFold_hypothetical_protein	3d2k-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3d2k-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with [7-(2-{2-[3-(3-chloro-phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3-d]pyrimidin-1-yl]-acetic acid	0.150	223	188	55	277	7	228	3.235E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	6d3k-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6d3k-assembly2.cif.gz_B Crystal structure of unphosphorylated human PKR kinase domain in complex with ADP	0.108	244	207	50	282	10	253	1.747E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_C ASK1 kinase domain in complex with Compound 11	0.145	215	181	59	273	15	227	1.747E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	5dr2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5dr2-assembly1.cif.gz_A Aurora A Kinase in Complex with AA30 and ATP in Space Group P6122	0.129	248	201	55	286	8	255	5.990E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_D Structure of human phosphorylase kinase, gamma 2	0.121	252	196	55	278	16	267	1.954E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	6x8g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6x8g-assembly1.cif.gz_A Crystal structure of TYK2 with Compound 22	0.122	272	217	55	302	10	281	1.848E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	0.107	225	197	55	276	5	229	5.064E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	3s95-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3s95-assembly2.cif.gz_B Crystal structure of the human LIMK1 kinase domain in complex with staurosporine	0.123	275	221	55	307	13	287	1.396E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	7a1z-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7a1z-assembly1.cif.gz_A Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 6-bromo-5-chloro-1H-triazolo[4,5-b]pyridine	0.127	266	215	55	301	35	300	2.601E-06	122
LOKIASV2_0914_ESMFold_hypothetical_protein	3vul-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3vul-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	0.134	229	193	52	280	19	242	3.640E-06	122
LOKIASV2_0914_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.095	204	175	52	245	8	211	2.586E-05	122
LOKIASV2_0914_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A Crystal Structure of PF11_0147	0.128	260	208	51	289	15	274	4.555E-06	122
LOKIASV2_0914_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.119	237	199	55	281	4	240	5.990E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	6vre-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6vre-assembly1.cif.gz_A Structure of ASK1 bound to BIO-1772961	0.151	233	180	59	291	15	227	1.320E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	5we8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5we8-assembly1.cif.gz_A Crystal structure of WNK1 in complex with N-{(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-N-methylquinoline-4-carboxamide (compound 8)	0.139	251	201	53	286	14	264	1.055E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	7up7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	0.107	267	224	55	306	10	276	1.055E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	0.141	226	192	51	274	9	234	1.652E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	3kn6-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3kn6-assembly2.cif.gz_B Crystal structure of the C-terminal kinase domain of MSK1	0.104	271	225	59	310	17	287	7.975E-06	121
LOKIASV2_0914_ESMFold_hypothetical_protein	5m5a-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5m5a-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	0.159	239	191	45	283	4	231	1.652E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 10	0.134	252	204	55	290	12	263	5.095E-06	121
LOKIASV2_0914_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C DYRK1A in complex with XMD14-124	0.124	241	205	55	289	26	266	2.067E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.153	275	213	3	277	27	278	1.562E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	0.137	298	255	3	299	24	321	6.741E-06	121
LOKIASV2_0914_ESMFold_hypothetical_protein	5hvu-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5hvu-assembly1.cif.gz_B Rho-associated protein kinase 1 (ROCK 1) in complex with a pyridine thiazole piperidine inhibitor	0.131	298	237	26	299	45	342	8.920E-06	121
LOKIASV2_0914_ESMFold_hypothetical_protein	6c2y-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6c2y-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257142	0.128	238	197	46	272	147	384	2.586E-05	121
LOKIASV2_0914_ESMFold_hypothetical_protein	6cpf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6cpf-assembly1.cif.gz_A Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP in an active conformation	0.137	242	199	55	286	7	248	1.747E-05	120
LOKIASV2_0914_ESMFold_hypothetical_protein	5drd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5drd-assembly1.cif.gz_A Aurora A Kinase in Complex with ATP in Space Group P6122	0.139	239	191	55	277	8	246	6.335E-05	120
LOKIASV2_0914_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I	LOKIASV2_0914_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.128	253	218	49	301	15	265	1.241E-04	120
LOKIASV2_0914_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.122	233	202	53	283	24	256	1.652E-05	120
LOKIASV2_0914_ESMFold_hypothetical_protein	4fv8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fv8-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E63	0.153	255	211	52	301	17	271	5.095E-06	120
LOKIASV2_0914_ESMFold_hypothetical_protein	3anr-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3anr-assembly2.cif.gz_B human DYRK1A/harmine complex	0.136	242	206	55	294	28	269	1.248E-05	120
LOKIASV2_0914_ESMFold_hypothetical_protein	7udq-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7udq-assembly1.cif.gz_A Crystal structure of COQ8A-CA157 inhibitor complex in space group P1	0.129	309	227	52	313	60	368	8.434E-06	120
LOKIASV2_0914_ESMFold_hypothetical_protein	6jmf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6jmf-assembly1.cif.gz_A Crystal structure of human tyrosine-protein kinase Fes/Fps in complex with compound 4	0.142	260	197	55	285	113	372	1.848E-05	120
LOKIASV2_0914_ESMFold_hypothetical_protein	5czo-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5czo-assembly2.cif.gz_B Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.129	259	215	56	303	12	270	2.601E-06	120
LOKIASV2_0914_ESMFold_hypothetical_protein	7up6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7up6-assembly1.cif.gz_A Crystal structure of C-terminal domain of MSK1 in complex with in covalently bound literature RSK2 inhibitor pyrrolopyrimidine cyanoacrylamide compound 25 (co-crystal)	0.102	238	211	59	294	16	253	2.312E-05	119
LOKIASV2_0914_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B Structure of ASK1 bound to BIO-1772961	0.142	233	179	59	291	17	226	3.421E-05	119
LOKIASV2_0914_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	0.109	236	198	55	277	9	244	3.235E-05	119
LOKIASV2_0914_ESMFold_hypothetical_protein	8tuc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8tuc-assembly1.cif.gz_A Unphosphorylated CaMKK2 in complex with CC-8977	0.142	268	201	51	285	5	272	2.445E-05	119
LOKIASV2_0914_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_A-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	0.125	253	199	55	282	41	293	5.388E-06	119
LOKIASV2_0914_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_A Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.131	306	253	8	299	32	337	6.027E-06	119
LOKIASV2_0914_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	0.101	276	216	46	286	147	422	2.186E-05	119
LOKIASV2_0914_ESMFold_hypothetical_protein	4bie-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bie-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.159	235	173	59	293	16	222	2.186E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	7bjr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7bjr-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 18	0.129	222	192	55	276	6	227	1.954E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	5os2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5os2-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	0.141	244	198	55	286	8	251	3.059E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.133	242	205	60	301	25	262	8.866E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.131	263	221	55	309	12	274	9.434E-06	118
LOKIASV2_0914_ESMFold_hypothetical_protein	3h9o-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3h9o-assembly1.cif.gz_A Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9	0.132	264	213	51	296	6	269	4.047E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	0.133	255	204	51	286	9	263	4.281E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.122	272	203	55	286	12	283	9.977E-06	118
LOKIASV2_0914_ESMFold_hypothetical_protein	3ri1-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3ri1-assembly2.cif.gz_B Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.120	268	223	55	308	15	282	1.477E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	0.109	224	197	55	276	9	232	2.892E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	0.117	292	216	41	286	2	293	7.130E-06	118
LOKIASV2_0914_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	0.127	253	195	55	278	34	286	7.975E-06	118
LOKIASV2_0914_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A Crystal structure of ERK2/DCC peptide complex	0.143	265	213	52	301	14	278	4.307E-06	118
LOKIASV2_0914_ESMFold_hypothetical_protein	5aik-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	5aik-assembly4.cif.gz_D Human DYRK1A in complex with LDN-211898	0.134	214	184	55	267	27	240	2.735E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_A Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain	0.120	227	187	59	271	15	241	3.235E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_H	LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_H CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.155	271	222	3	273	27	290	5.064E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.137	257	211	27	272	103	359	2.445E-05	118
LOKIASV2_0914_ESMFold_hypothetical_protein	7kx6-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7kx6-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with XMD8-85	0.142	240	198	47	278	3	242	5.664E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D Aurora-2 T287D T288D complexed with PHA-680632	0.119	236	204	55	286	8	243	6.335E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	0.167	215	173	59	273	16	224	3.235E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	0.162	229	187	55	278	10	238	5.664E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	4zji-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4zji-assembly2.cif.gz_B PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.132	259	220	51	304	15	273	1.562E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	0.149	224	184	51	274	9	225	3.235E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	7up8-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7up8-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	0.100	240	212	59	294	17	256	7.975E-06	117
LOKIASV2_0914_ESMFold_hypothetical_protein	7up4-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7up4-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	0.122	269	220	59	309	17	285	1.652E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	6gue-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6gue-assembly1.cif.gz_A CDK2/CyclinA in complex with AZD5438	0.121	213	180	55	267	6	211	5.356E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	6bdn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6bdn-assembly1.cif.gz_A Crystal structure of human TAO3 kinase binding ADP	0.148	285	220	51	309	15	299	1.180E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	0.145	239	203	45	283	5	242	4.817E-06	117
LOKIASV2_0914_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	0.142	299	223	55	315	32	330	7.130E-06	117
LOKIASV2_0914_ESMFold_hypothetical_protein	5a3x-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5a3x-assembly1.cif.gz_A DYRK1A in complex with hydroxy benzothiazole fragment	0.121	201	166	52	241	21	221	8.866E-05	117
LOKIASV2_0914_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	0.131	247	200	56	286	18	264	7.975E-06	117
LOKIASV2_0914_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.131	293	250	7	299	35	323	5.095E-06	117
LOKIASV2_0914_ESMFold_hypothetical_protein	3dj7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3dj7-assembly1.cif.gz_A Crystal structure of the mouse Aurora-A catalytic domain (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with Compound 130.	0.137	231	191	55	276	9	239	4.281E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	7q7c-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7q7c-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ADP at atmospheric pressure	0.155	230	183	47	276	8	224	6.700E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	7up5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7up5-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	0.105	246	214	55	294	10	255	1.562E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	3sc1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3sc1-assembly1.cif.gz_A Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery	0.138	253	203	51	286	8	260	5.064E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	3hrc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3hrc-assembly1.cif.gz_A Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP	0.127	268	213	51	295	5	272	5.990E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	0.141	253	203	41	293	5	241	1.180E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	5a4e-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5a4e-assembly2.cif.gz_B DYRK1A in complex with methoxy benzothiazole fragment	0.121	248	215	52	297	22	269	1.055E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	5zn3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5zn3-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148S mutant	0.127	213	176	55	267	38	240	1.388E-04	116
LOKIASV2_0914_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	0.126	263	215	55	301	38	300	1.055E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C DYRK1A in complex with XMD7-112	0.133	216	186	53	267	24	239	4.527E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A Crystal Structure of F327A/K285P Mutant of cAMP-dependent Protein Kinase	0.136	248	209	30	272	2	249	7.086E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	5kks-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5kks-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole inhibitor	0.122	312	256	7	299	35	346	1.562E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	0.131	249	202	46	279	146	394	2.186E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	5he3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5he3-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224411	0.099	289	232	46	303	147	435	2.445E-05	116
LOKIASV2_0914_ESMFold_hypothetical_protein	6d3k-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6d3k-assembly2.cif.gz_C Crystal structure of unphosphorylated human PKR kinase domain in complex with ADP	0.106	249	220	50	298	8	254	2.586E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	0.143	241	195	59	286	16	256	1.652E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor	0.146	223	182	51	273	6	219	2.430E-04	115
LOKIASV2_0914_ESMFold_hypothetical_protein	3kn6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3kn6-assembly1.cif.gz_A Crystal structure of the C-terminal kinase domain of MSK1	0.096	265	227	59	310	17	281	1.180E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.142	213	175	55	267	5	209	2.586E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	5l6w-assembly1.cif.gz_L	LOKIASV2_0914_ESMFold_hypothetical_protein	5l6w-assembly1.cif.gz_L Structure Of the LIMK1-ATPgammaS-CFL1 Complex	0.112	269	215	55	297	13	281	1.180E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336)	0.124	233	194	55	277	39	271	5.064E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	5a4q-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5a4q-assembly2.cif.gz_B DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT	0.134	246	203	55	289	28	273	2.186E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C DYRK1A in complex with JWC-055	0.138	214	183	55	267	26	239	4.527E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C Crystal structure of human unphosphorylated p38gamma	0.156	267	210	52	301	20	286	2.326E-06	115
LOKIASV2_0914_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.143	293	237	7	299	35	312	5.698E-06	115
LOKIASV2_0914_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A Crystal structure of G protein-coupled receptor kinase 2 in complex with a a rationally designed paroxetine derivative	0.127	271	219	27	278	130	400	2.067E-05	115
LOKIASV2_0914_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-293 in complex with ATP	0.143	227	184	50	276	9	224	9.917E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	5aad-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5aad-assembly1.cif.gz_A Aurora A kinase bound to an imidazopyridine inhibitor (7a)	0.143	238	198	55	286	8	245	1.836E-04	114
LOKIASV2_0914_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	0.128	235	197	59	285	21	255	1.477E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.128	253	215	49	301	20	267	1.642E-04	114
LOKIASV2_0914_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_A Structure of RIP2K(L294F) with bound AMPPCP	0.144	225	191	50	274	10	233	4.047E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	1h1w-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1h1w-assembly1.cif.gz_A High resolution crystal structure of the human PDK1 catalytic domain	0.133	269	212	51	296	10	278	5.356E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	0.139	234	196	50	283	20	248	2.586E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	1yhw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1yhw-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with one point mutations (K299R)	0.124	289	229	41	302	3	291	2.186E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2t-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2t-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	0.126	248	212	45	287	2	249	9.977E-06	114
LOKIASV2_0914_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	0.132	261	222	45	301	4	264	2.751E-06	114
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.128	255	211	45	287	3	257	1.652E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	0.129	285	206	55	292	34	318	1.248E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	0.127	264	215	55	301	34	297	6.741E-06	114
LOKIASV2_0914_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A Crystal structure of CK2 with compound 7b	0.122	246	203	55	286	38	283	3.618E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	7aya-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7aya-assembly2.cif.gz_B Crystal structure of CK2 bound by compound 9	0.115	243	204	55	286	39	281	3.059E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.124	266	219	56	306	12	277	4.072E-06	114
LOKIASV2_0914_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine	0.135	240	198	50	289	10	239	4.788E-05	114
LOKIASV2_0914_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2 Structure of mitogen-activated protein kinase kinase kinase 5	0.148	235	181	59	293	16	228	6.700E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	3umw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3umw-assembly1.cif.gz_A Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one	0.131	261	200	55	285	3	263	4.788E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.136	227	192	50	276	8	230	2.735E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	3pwy-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3pwy-assembly1.cif.gz_A Crystal structure of an extender (SPD28345)-modified human PDK1 complex 2	0.137	264	211	51	295	10	273	2.735E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5hvj-assembly2.cif.gz_B Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.119	270	204	55	286	11	280	1.747E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	2cjm-assembly2.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2cjm-assembly2.cif.gz_A Mechanism of CDK inhibition by active site phosphorylation: CDK2 Y15p T160p in complex with cyclin A structure	0.126	213	179	55	267	5	210	3.421E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	2j51-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2j51-assembly1.cif.gz_A Crystal structure of Human STE20-like kinase bound to 5-Amino-3-((4-(aminosulfonyl)phenyl)amino) -N-(2,6-difluorophenyl)-1H-1,2,4-triazole- 1-carbothioamide	0.136	274	213	53	299	13	286	5.990E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	7rj7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7rj7-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND 2-(1-AMINO-3-METHYLBUTYL)-6- (PYRIDIN-4-YL)QUINOLINE-4-CARBONITRILE	0.103	282	210	50	284	7	288	8.434E-06	113
LOKIASV2_0914_ESMFold_hypothetical_protein	5zn2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5zn2-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148A mutant	0.130	213	176	55	267	38	240	1.736E-04	113
LOKIASV2_0914_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	0.120	253	196	55	278	35	287	1.848E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.159	271	215	3	273	29	285	2.312E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_A ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.127	307	254	8	299	35	341	1.652E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	0.129	302	238	26	299	45	346	2.312E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	5uuu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uuu-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.131	260	221	18	272	39	298	4.047E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.112	283	234	13	277	117	399	1.848E-05	113
LOKIASV2_0914_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_A Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.138	241	201	53	286	6	246	1.049E-04	112
LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G	LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.132	232	190	52	283	6	225	1.241E-04	112
LOKIASV2_0914_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	0.143	235	183	59	293	16	230	6.700E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F	LOKIASV2_0914_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.147	226	178	56	281	12	221	5.064E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	5uir-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uir-assembly1.cif.gz_A Crystal structure of IRAK4 in complex with compound 11	0.117	248	195	59	280	23	270	3.421E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	5lvp-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.145	218	180	55	272	10	221	4.527E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	4zji-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4zji-assembly1.cif.gz_A PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.142	259	217	51	304	15	273	3.059E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_A Structure of Aurora Kinase A in complex with activator peptide	0.134	266	213	40	286	10	275	2.312E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	0.132	272	213	51	296	5	276	4.527E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	4aw1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4aw1-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Compound PS210 Bound to the PIF-Pocket	0.140	255	202	51	286	12	266	9.377E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	4ct1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4ct1-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket	0.127	271	212	51	294	5	275	5.990E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_B Structure of MELK in complex with inhibitors	0.146	249	196	53	283	9	257	9.434E-06	112
LOKIASV2_0914_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B Crystal structure of human CK2 in complex with inositol hexakisphosphate	0.114	248	205	55	286	37	284	2.186E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.146	260	213	52	301	14	273	2.067E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	0.137	293	236	26	299	45	337	2.586E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_A ROCK 1 bound to a pyridine thiazole inhibitor	0.118	300	241	26	299	44	343	2.892E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole piperazine inhibitor	0.126	302	239	26	299	45	346	2.445E-05	112
LOKIASV2_0914_ESMFold_hypothetical_protein	5uox-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5uox-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.131	225	182	59	283	16	225	5.356E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D Structure of dephosphorylated Aurora A (122-403) bound to TPX2 and AMPPCP	0.145	242	198	55	286	10	251	1.173E-04	111
LOKIASV2_0914_ESMFold_hypothetical_protein	5os5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5os5-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	0.131	248	201	55	286	10	257	1.312E-04	111
LOKIASV2_0914_ESMFold_hypothetical_protein	7q7d-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7q7d-assembly1.cif.gz_A Room temperature structure of the human Serine/Threonine Kinase 17B (STK17B/DRAK2) in complex with ATP/ADP at 111 MPa helium gas pressure in a sapphire capillary	0.129	240	208	47	286	8	247	4.527E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	0.123	272	196	59	283	7	278	9.977E-06	111
LOKIASV2_0914_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	0.128	273	214	51	296	7	279	5.356E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	6qf4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6qf4-assembly1.cif.gz_A X-Ray structure of human Serine/Threonine Kinase 17B (STK17B) aka DRAK2 in complex with ADP obtained by on-chip soaking	0.145	229	187	48	276	9	228	1.049E-04	111
LOKIASV2_0914_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_D Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.139	257	217	51	303	12	268	1.049E-04	111
LOKIASV2_0914_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	0.132	279	217	59	309	21	299	1.562E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	0.088	212	192	55	266	6	216	5.990E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2	LOKIASV2_0914_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2 Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012	0.128	269	221	51	304	27	295	1.173E-04	111
LOKIASV2_0914_ESMFold_hypothetical_protein	1na7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1na7-assembly1.cif.gz_A Crystal structure of the catalytic subunit of human protein kinase CK2	0.119	213	181	55	267	37	242	1.173E-04	111
LOKIASV2_0914_ESMFold_hypothetical_protein	8buc-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8buc-assembly1.cif.gz_B Structure of DDB1 bound to dCeMM3-engaged CDK12-cyclin K	0.149	277	213	51	301	11	287	1.180E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	6xx7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6xx7-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal in complex with ANP	0.128	253	194	55	278	35	287	7.540E-06	111
LOKIASV2_0914_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A Crystal structure of Fus3 phosphorylated on Tyr182	0.131	228	196	55	280	14	241	7.927E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A Design, synthesis, biological evaluation, and X-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-Jun N-terminal kinase (JNK)	0.140	232	195	52	279	19	250	1.320E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative	0.137	244	204	51	294	18	254	6.027E-06	111
LOKIASV2_0914_ESMFold_hypothetical_protein	4nct-assembly5.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4nct-assembly5.cif.gz_B Human DYRK1A in complex with PKC412	0.112	240	209	55	294	28	263	5.990E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	0.125	251	204	56	289	17	267	2.892E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2	LOKIASV2_0914_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2 ROCK2 IN COMPLEX WITH COMPOUND 12	0.153	271	207	3	273	27	271	3.059E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_A ROCK 1 bound to azaindole thiazole piperazine inhibitor	0.118	298	241	26	299	44	341	1.248E-05	111
LOKIASV2_0914_ESMFold_hypothetical_protein	3cok-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3cok-assembly1.cif.gz_A Crystal structure of PLK4 kinase	0.110	216	186	55	264	14	229	2.298E-04	110
LOKIASV2_0914_ESMFold_hypothetical_protein	7kxw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7kxw-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with DCLK1-IN-1	0.144	239	202	50	286	6	244	1.049E-04	110
LOKIASV2_0914_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.129	239	195	55	279	9	247	1.049E-04	110
LOKIASV2_0914_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A Catalytic domain of PknB kinase from Mycobacterium tuberculosis	0.129	247	198	55	301	10	237	6.335E-05	110
LOKIASV2_0914_ESMFold_hypothetical_protein	5ar3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ar3-assembly1.cif.gz_A RIP2 Kinase Catalytic Domain (1 - 310) complex with AMP-PCP	0.117	268	223	51	304	11	278	1.109E-04	110
LOKIASV2_0914_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.152	222	182	51	272	8	223	5.356E-05	110
LOKIASV2_0914_ESMFold_hypothetical_protein	4ypd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4ypd-assembly1.cif.gz_A Crystal Structure of DAPK1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine	0.140	254	201	53	287	11	264	1.173E-04	110
LOKIASV2_0914_ESMFold_hypothetical_protein	4o0r-assembly3.cif.gz_B-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4o0r-assembly3.cif.gz_B-2 Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors	0.139	277	222	41	299	3	279	3.235E-05	110
LOKIASV2_0914_ESMFold_hypothetical_protein	3mtl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3mtl-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with Indirubin E804	0.158	223	180	55	277	5	219	9.977E-06	110
LOKIASV2_0914_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A Crystal Structure of CK2alpha with Compound 5 bound	0.124	240	202	55	294	38	269	1.388E-04	110
LOKIASV2_0914_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	0.121	253	200	55	282	40	292	1.320E-05	110
LOKIASV2_0914_ESMFold_hypothetical_protein	5ts8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ts8-assembly1.cif.gz_A Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE	0.130	253	194	55	278	34	286	4.281E-05	110
LOKIASV2_0914_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A Crystal structure of BubR1 kinase domain	0.134	281	217	55	306	51	331	3.235E-05	110
LOKIASV2_0914_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	0.120	241	200	46	273	147	387	8.383E-05	110
LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly5.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly5.cif.gz_E GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.137	232	178	52	283	6	212	1.642E-04	109
LOKIASV2_0914_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	0.115	236	196	55	277	7	242	5.356E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B Crystal structure of Cyclin-G associated kinase (GAK) complexed with selective 12i inhibitor	0.148	245	205	56	297	16	260	1.642E-04	109
LOKIASV2_0914_ESMFold_hypothetical_protein	8cur-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8cur-assembly1.cif.gz_A Crystal structure of Cdk2 in complex with Cyclin A inhibitor 6-[(E)-2-(4-chlorophenyl)ethenyl]-2-{[(2R)-3-(4-hydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]carbamoyl}quinoline-4-carboxylic acid	0.135	217	165	51	267	2	193	1.836E-04	109
LOKIASV2_0914_ESMFold_hypothetical_protein	3lm0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3lm0-assembly1.cif.gz_A Crystal Structure of human Serine/Threonine Kinase 17B (STK17B)	0.121	237	203	48	279	9	245	5.664E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	4zjj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4zjj-assembly1.cif.gz_A PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide	0.141	246	198	41	286	3	233	1.848E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B P21-activated kinase 1 in complex with a 4-azaindole inhibitor	0.145	265	212	51	299	14	278	2.445E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A CDK2/CyclinA in complex with SU9516	0.112	213	182	55	267	6	211	3.235E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B Crystal structure of CaMKII-actinin complex bound to ADP	0.095	225	200	55	276	10	234	2.172E-04	109
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2p-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2p-assembly1.cif.gz_C Structure of MELK in complex with inhibitors	0.155	235	190	49	283	7	232	1.652E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	0.119	266	217	55	301	39	304	2.586E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental Syndrome	0.123	248	203	55	286	39	286	7.086E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subunit)	0.125	291	235	29	297	3	293	5.356E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	7mt9-assembly1.cif.gz_G	LOKIASV2_0914_ESMFold_hypothetical_protein	7mt9-assembly1.cif.gz_G Rhodopsin kinase (GRK1) in complex with rhodopsin	0.140	259	207	35	276	2	260	7.495E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	3o2m-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3o2m-assembly1.cif.gz_A Crystal Structure of JNK1-alpha1 isoform complex with a biaryl tetrazol (A-82118)	0.120	246	210	52	291	19	264	1.116E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	5wne-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5wne-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.131	303	254	7	299	36	338	1.116E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B Crystal Structure of ROCK 1 bound to YB-15-QD37	0.123	306	256	7	299	34	339	5.064E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D Crystal Structure of ROCK 1 bound to YB-15-QD37	0.126	306	255	7	299	34	339	3.618E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	3tv7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3tv7-assembly1.cif.gz_A Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342	0.130	302	238	26	299	41	342	7.927E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A bovine GRK2 in complex with human Gbetagamma subunits and CCG258208 (14as)	0.135	259	214	26	273	128	386	5.064E-05	109
LOKIASV2_0914_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.180	183	144	59	241	15	190	7.495E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6oyt-assembly2.cif.gz_D ASK1 kinase domain in complex with GS-4997	0.133	233	189	59	277	20	252	4.788E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	2z2w-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2z2w-assembly1.cif.gz_A Human Wee1 kinase complexed with inhibitor PF0335770	0.094	252	214	50	286	6	257	2.054E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A MST3 in complex with compound MRIA9	0.131	231	188	49	279	7	223	1.388E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A Crystal structure of the human cyclin G associated kinase (GAK)	0.141	232	196	56	284	18	249	1.468E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	0.132	266	212	51	295	5	270	1.049E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29	0.129	268	226	49	308	12	279	3.827E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	5mrd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	0.135	272	211	51	295	5	276	7.086E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A Drosophila melanogaster UNC89 Protein Kinase Domain 1 (apo)	0.137	250	193	55	279	4	253	1.241E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	5e8y-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5e8y-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH STAUROSPORINE	0.128	212	178	52	263	2	206	3.040E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_C Structure of MELK in complex with inhibitors	0.128	247	208	49	287	6	252	1.477E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A Crystal Structure of CK2alpha with CAM187 bound	0.118	245	204	55	286	38	282	1.173E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	6xx9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6xx9-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form III	0.109	250	199	55	278	36	285	2.892E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A Crystal structure of the CK2a1-go289 complex	0.123	265	215	55	300	39	303	2.186E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	3juh-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3juh-assembly2.cif.gz_B Crystal structure of a mutant of human protein kinase CK2alpha with altered cosubstrate specificity	0.115	253	197	55	278	39	291	3.059E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	6l22-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6l22-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y with hematein	0.121	266	216	55	301	39	304	2.445E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	2ghm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2ghm-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449	0.133	255	216	52	301	19	273	8.434E-06	108
LOKIASV2_0914_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	0.121	261	216	55	301	14	274	1.562E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors	0.120	291	236	29	297	2	292	1.468E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	6ej4-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6ej4-assembly2.cif.gz_B DYRK1A in complex with XMD7-112	0.132	195	161	55	241	28	222	2.054E-04	108
LOKIASV2_0914_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with open-chain Fasudil-derivative 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium (soaked)	0.132	308	244	23	304	2	309	6.335E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A Crystal structure of Mitogen-activated Protein Kinase Mps1 in Magnaporthe oryzae	0.139	243	193	55	279	20	262	9.377E-05	108
LOKIASV2_0914_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.152	239	192	51	277	156	394	6.374E-06	108
LOKIASV2_0914_ESMFold_hypothetical_protein	2wqe-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2wqe-assembly1.cif.gz_A Structure of S155R Aurora-A somatic mutant	0.126	229	198	51	279	5	232	7.927E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	0.125	227	195	50	276	4	227	2.875E-04	107
LOKIASV2_0914_ESMFold_hypothetical_protein	2in6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2in6-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD311839	0.093	249	214	50	286	6	254	2.570E-04	107
LOKIASV2_0914_ESMFold_hypothetical_protein	6xih-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6xih-assembly1.cif.gz_A Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile	0.135	240	196	59	286	15	254	4.047E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	1p4f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1p4f-assembly1.cif.gz_A DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT	0.118	257	209	53	290	11	267	7.927E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	5jzj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5jzj-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with AMPPN	0.154	255	195	48	279	12	266	1.942E-04	107
LOKIASV2_0914_ESMFold_hypothetical_protein	3ion-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3ion-assembly1.cif.gz_A PDK1 in complex with Compound 8h	0.125	261	214	51	295	6	266	8.866E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	3qd0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3qd0-assembly1.cif.gz_A Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-N-phenyl-3-piperidinecarboxamide	0.151	222	179	51	272	8	219	5.356E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	6rn8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6rn8-assembly1.cif.gz_A RIP2 Kinase Catalytic Domain complex with 2(4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)quinazolin7yl)oxy)ethyl phosphate	0.143	224	187	51	274	12	230	2.054E-04	107
LOKIASV2_0914_ESMFold_hypothetical_protein	6q49-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6q49-assembly1.cif.gz_A CDK2 in complex with FragLite6	0.126	217	177	51	267	2	204	7.495E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	5o0y-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5o0y-assembly1.cif.gz_A TLK2 kinase domain from human	0.109	272	197	55	276	8	279	1.642E-04	107
LOKIASV2_0914_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A CASK-4M CaM Kinase Domain, AMPPNP-Mn2+	0.124	297	229	50	311	5	301	4.527E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	0.083	261	214	55	288	8	268	5.064E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	3ocg-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3ocg-assembly1.cif.gz_A P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitor	0.121	254	219	52	301	20	273	1.477E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E Crystal Structure of Arg280Ala mutant of Catalytic subunit of cAMP-dependent Protein Kinase	0.124	266	228	27	287	4	269	7.495E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.140	297	248	3	299	27	315	6.700E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	7pwd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7pwd-assembly1.cif.gz_A Structure of an inhibited GRK2-G-beta and G-gamma complex	0.130	257	213	27	272	133	389	5.664E-05	107
LOKIASV2_0914_ESMFold_hypothetical_protein	5v24-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5v24-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.153	232	192	59	286	15	246	6.335E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3zxt-assembly1.cif.gz_B Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.138	245	201	53	286	6	250	9.377E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	0.133	239	188	59	276	16	254	3.421E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	4bn1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bn1-assembly1.cif.gz_A Crystal structure of V174M mutant of Aurora-A kinase	0.130	244	193	55	277	9	252	4.527E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	5jzn-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5jzn-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with NVP-TAE684	0.158	255	194	48	278	6	260	1.109E-04	106
LOKIASV2_0914_ESMFold_hypothetical_protein	8p4z-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8p4z-assembly2.cif.gz_B Crystal structure of the human CDK7 kinase domain in complex with LDC4297	0.149	213	160	55	267	5	193	5.664E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	5uyj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uyj-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	0.134	267	209	55	296	8	274	5.990E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	5a14-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5a14-assembly1.cif.gz_A Human CDK2 with type II inhibitor	0.142	217	172	51	267	2	203	7.495E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	5ar5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ar5-assembly1.cif.gz_A RIP2 Kinase Catalytic Domain (1 - 310) complex with Benzimidazole	0.132	272	220	50	304	12	283	2.570E-04	106
LOKIASV2_0914_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discovery	0.132	272	201	50	282	19	290	2.445E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B Structure of GAK kinase in complex with a nanobody	0.129	280	217	56	305	16	295	1.173E-04	106
LOKIASV2_0914_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D Crystal Structure of the CK2 Tetrameric Holoenzyme	0.121	240	205	55	294	38	271	2.298E-04	106
LOKIASV2_0914_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_A GSK-3 Beta complexed with Indirubin-3'-monoxime	0.136	215	179	53	267	22	229	3.235E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine	0.123	285	229	25	286	4	288	2.054E-04	106
LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C Crystal Structure of ROCK 1 bound to YB-15-QD37	0.132	305	253	7	299	34	338	3.421E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	7jnt-assembly3.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	7jnt-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.133	311	257	3	299	29	339	3.235E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.136	312	256	3	299	29	340	5.356E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha	0.128	300	241	28	304	65	364	7.495E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.114	249	204	56	286	10	258	7.927E-05	106
LOKIASV2_0914_ESMFold_hypothetical_protein	3zxt-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	3zxt-assembly2.cif.gz_D Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	0.143	238	197	50	287	4	234	1.312E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A Crystal structure of benzamide 9 bound to AuroraA	0.139	230	191	55	277	9	238	6.335E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	5vda-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5vda-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with RAC-IV-101, a MK1775 analogue	0.121	252	206	50	301	4	238	4.500E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	5jzj-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5jzj-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with AMPPN	0.163	251	192	50	279	6	256	1.942E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.119	243	200	59	286	21	263	2.586E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	3bqr-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	3bqr-assembly1.cif.gz_A-2 Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with an imidazo-pyridazine ligand	0.133	264	202	55	288	8	271	2.430E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	2pe0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2pe0-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX	0.132	246	209	51	292	7	252	1.736E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	8d6e-assembly2.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8d6e-assembly2.cif.gz_A Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	0.096	244	209	55	286	31	274	1.241E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	5uy6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uy6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	0.128	229	184	55	266	8	236	1.388E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	5hvk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5hvk-assembly1.cif.gz_A Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1	0.106	282	207	55	287	17	298	6.335E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	4mao-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4mao-assembly1.cif.gz_A RSK2 T493M C-Terminal Kinase Domain in Complex with RMM58	0.129	276	208	55	294	9	284	1.109E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H	LOKIASV2_0914_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 8 monomers in the asymmetric unit	0.125	291	222	53	307	11	301	6.700E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A Complex structure of cyclin G-associated kinase with gefitinib	0.119	277	219	56	305	19	295	8.383E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	4d9u-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4d9u-assembly1.cif.gz_A Rsk2 C-terminal Kinase Domain, (E)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate	0.114	263	208	50	285	12	274	1.468E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	0.137	299	224	55	315	27	325	9.977E-06	105
LOKIASV2_0914_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_B GSK-3 Beta complexed with AMP-PNP	0.137	236	196	53	288	22	249	2.586E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	0.132	245	210	52	294	18	262	8.920E-06	105
LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_A Crystal Structure of ROCK 1 bound to YB-15-QD37	0.131	306	254	7	299	34	339	4.788E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.137	312	252	7	299	35	346	2.445E-05	105
LOKIASV2_0914_ESMFold_hypothetical_protein	5he1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5he1-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224062	0.111	253	205	46	277	148	400	1.109E-04	105
LOKIASV2_0914_ESMFold_hypothetical_protein	3h0z-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	3h0z-assembly3.cif.gz_C Aurora A in complex with a bisanilinopyrimidine	0.132	227	193	55	277	9	235	2.570E-04	104
LOKIASV2_0914_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	0.103	231	204	56	283	14	244	1.642E-04	104
LOKIASV2_0914_ESMFold_hypothetical_protein	6e2o-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6e2o-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	0.157	243	181	59	301	15	230	7.927E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	4cv8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4cv8-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.118	229	195	55	276	11	239	7.086E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	6vbz-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6vbz-assembly2.cif.gz_B Crystal structure of the rat MLKL pseudokinase domain	0.136	229	189	50	278	7	226	8.383E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1	0.107	240	195	55	294	7	225	1.312E-04	104
LOKIASV2_0914_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	0.126	237	198	59	286	22	258	8.866E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	2g1t-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	2g1t-assembly4.cif.gz_D A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.134	258	216	56	305	19	276	2.445E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	7b8w-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7b8w-assembly1.cif.gz_A Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.119	259	212	56	297	12	270	4.281E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	6i2y-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6i2y-assembly1.cif.gz_A Human STK10 bound to Foretinib	0.138	265	220	51	306	10	274	2.054E-04	104
LOKIASV2_0914_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	0.110	269	208	55	289	7	275	2.445E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	1ukh-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1ukh-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	0.139	226	187	52	277	17	234	9.434E-06	104
LOKIASV2_0914_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A Crystal structure of CASK-CaMK in complex with Mint1-CID	0.134	293	223	50	307	4	296	6.335E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A The Structure of CK2alpha with CCh507 bound	0.121	248	203	55	286	38	285	1.552E-04	104
LOKIASV2_0914_ESMFold_hypothetical_protein	1j91-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1j91-assembly1.cif.gz_A Crystal structure of Z. mays CK2 kinase alpha subunit in complex with the ATP-competitive inhibitor 4,5,6,7-tetrabromobenzotriazole	0.111	253	198	55	278	34	286	1.747E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	3u87-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3u87-assembly1.cif.gz_A Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydrolysable ATP-analogue	0.119	248	204	55	286	39	286	6.700E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	0.120	266	216	55	301	39	304	3.827E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2 Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.121	293	240	26	299	43	335	5.990E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.123	296	239	26	299	45	340	8.383E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.122	303	256	7	299	36	338	3.618E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G	LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.143	271	226	3	273	29	293	8.866E-05	104
LOKIASV2_0914_ESMFold_hypothetical_protein	7jij-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7jij-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.134	239	202	53	286	5	243	1.736E-04	104
LOKIASV2_0914_ESMFold_hypothetical_protein	3daj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3daj-assembly1.cif.gz_A Crystal structure of Aurora A complexed with an inhibitor discovered through site-directed dynamic tethering	0.124	223	193	55	277	8	228	1.942E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.134	232	192	55	277	8	239	1.552E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	2x6d-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2x6d-assembly1.cif.gz_A Aurora-A bound to an inhibitor	0.143	238	192	55	279	9	246	1.109E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	5wdy-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5wdy-assembly1.cif.gz_A Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	0.133	238	197	59	286	19	256	3.827E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2 Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.142	235	196	56	284	16	250	3.401E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	7quf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7quf-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CK156	0.139	237	186	59	295	19	235	1.642E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	5we8-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5we8-assembly2.cif.gz_B Crystal structure of WNK1 in complex with N-{(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-N-methylquinoline-4-carboxamide (compound 8)	0.138	250	196	59	286	20	269	2.067E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	3q4z-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3q4z-assembly1.cif.gz_B Structure of unphosphorylated PAK1 kinase domain	0.127	261	218	49	299	17	277	3.421E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	5k7g-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	5k7g-assembly4.cif.gz_D IRAK4 in complex with AZ3862	0.113	269	204	50	280	15	283	7.927E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	2qg5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2qg5-assembly1.cif.gz_A Cryptosporidium parvum calcium dependent protein kinase cgd7_1840	0.128	247	198	51	278	23	269	6.700E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	6q4a-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6q4a-assembly1.cif.gz_A CDK2 in complex with FragLite14	0.122	209	176	59	267	9	209	1.173E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308A mutations	0.119	274	215	53	297	9	282	2.570E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	5g6v-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5g6v-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.162	190	154	53	242	6	190	4.047E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	3mvj-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3mvj-assembly2.cif.gz_B Human cyclic AMP-dependent protein kinase PKA inhibitor complex	0.131	243	207	34	272	3	245	9.377E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_A GSK-3 Beta complexed with AMP-PNP	0.131	215	181	53	267	22	230	3.827E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	3dzo-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3dzo-assembly1.cif.gz_A Crystal structure of a rhoptry kinase from toxoplasma gondii	0.099	274	221	56	301	67	340	4.047E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A ROP18 kinase domain in complex with AMP-PNP and sucrose	0.126	279	214	56	301	61	339	4.527E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A Crystal structure of scCK2 alpha in complex with ATP	0.112	244	188	55	267	41	284	3.059E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	3ndm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3ndm-assembly1.cif.gz_A Crystal structure of Rho-Associated Protein Kinase (ROCK1) with a potent isoquinolone derivative	0.156	246	203	26	271	45	286	1.049E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.132	310	257	3	299	29	338	1.241E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	5wnf-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5wnf-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.128	303	255	7	299	36	338	2.735E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	5u7q-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5u7q-assembly3.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.132	272	233	3	274	29	297	8.866E-05	103
LOKIASV2_0914_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2 Crystal structure of CDC42 binding protein kinase alpha (MRCK alpha)	0.136	273	216	26	276	43	315	2.054E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	5ote-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	5ote-assembly1.cif.gz_A-2 MRCK beta in complex with BDP-00008900	0.120	282	231	26	288	51	332	1.109E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.143	219	186	56	273	10	228	2.430E-04	103
LOKIASV2_0914_ESMFold_hypothetical_protein	6n3l-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6n3l-assembly2.cif.gz_B Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents	0.133	229	177	55	283	8	212	4.500E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.113	230	199	55	279	8	237	1.942E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	2clq-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2clq-assembly2.cif.gz_B Structure of mitogen-activated protein kinase kinase kinase 5	0.147	240	194	59	286	16	255	5.990E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C Crystal structure of Nek7 SRS mutant bound to compound 51	0.124	256	219	51	306	7	257	5.064E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	5oop-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5oop-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with AMP-PNP	0.149	238	190	55	278	6	243	9.917E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	0.138	244	196	59	286	15	258	4.788E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	8qel-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8qel-assembly1.cif.gz_B PKR kinase domain- eIF2alpha in complex with compound	0.111	255	204	53	282	12	266	1.388E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	0.129	232	200	52	283	6	236	1.241E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	6aar-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6aar-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with purpurin	0.134	243	199	53	283	11	253	2.298E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I	0.111	270	212	50	288	3	272	1.468E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A Crystal Structure of the L1180T mutant Roco4 Kinase Domain from D. discoideum bound to AppCp	0.119	263	216	55	300	11	273	3.215E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	6vpm-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6vpm-assembly1.cif.gz_B TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, and in complex with AMP-PNP	0.135	239	195	55	281	26	264	6.700E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	8d6e-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8d6e-assembly1.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	0.095	246	208	55	285	31	276	1.552E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.147	238	193	52	289	5	231	8.866E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.109	264	222	55	304	14	277	1.942E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	5vcz-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5vcz-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Bosutinib isomer	0.092	247	210	55	286	44	290	1.642E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	5zn4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5zn4-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148N mutant	0.120	245	210	55	294	38	282	1.736E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor	0.142	241	198	53	293	22	253	2.312E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	0.149	256	212	52	301	17	272	2.186E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	0.145	256	214	51	301	17	272	2.067E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743	0.119	253	219	52	301	19	271	1.562E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	4dg3-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	4dg3-assembly1.cif.gz_E Crystal structure of R336A mutant of cAMP-dependent protein kinase with unphosphorylated turn motif.	0.131	281	223	29	286	2	282	1.109E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT	0.129	297	238	30	303	3	299	1.552E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	0.118	267	200	59	286	19	285	2.186E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with SPHINX31	0.119	268	197	59	283	22	289	5.356E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_F	LOKIASV2_0914_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_F CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.157	271	222	3	273	27	290	6.700E-05	102
LOKIASV2_0914_ESMFold_hypothetical_protein	4wot-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4wot-assembly1.cif.gz_C ROCK2 IN COMPLEX WITH 1426382-07-1	0.124	316	259	3	299	30	345	2.172E-04	102
LOKIASV2_0914_ESMFold_hypothetical_protein	3efw-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3efw-assembly2.cif.gz_B Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	0.140	225	191	55	277	9	233	1.736E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A Aurora A in complex with a bisanilinopyrimidine	0.129	235	201	55	286	7	241	3.215E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	2iwi-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2iwi-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1	0.117	171	128	45	215	4	149	3.196E-03	101
LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.092	245	210	55	286	8	252	1.388E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	5yvc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5yvc-assembly1.cif.gz_A Structure of CaMKK2 in complex with CKI-012	0.129	247	210	55	296	7	253	1.942E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_D Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.119	236	189	55	290	8	222	2.718E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	5op2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5op2-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with arylbenzamide LRRK2 inhibitor	0.129	257	204	55	289	7	263	1.109E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1	0.138	251	198	55	305	19	249	1.312E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.143	234	195	56	284	16	249	1.836E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	5nud-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5nud-assembly1.cif.gz_A FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.115	243	198	56	280	17	259	9.917E-05	101
LOKIASV2_0914_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2 Crystal structure of Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 in presence of indirubin E804	0.130	264	204	51	286	3	266	3.597E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2 Crystal structure of human Chk2 in complex with ADP	0.114	226	195	56	276	15	240	1.642E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor	0.130	213	172	55	267	5	203	1.312E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	5hvk-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5hvk-assembly2.cif.gz_C Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1	0.107	277	204	55	283	13	289	1.241E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_A Structure of MELK in complex with inhibitors	0.167	239	188	45	283	3	229	1.049E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	5cvg-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5cvg-assembly1.cif.gz_A Crystal Structure of CK2alpha with a novel closed conformation of the aD loop	0.120	266	216	55	301	37	302	8.866E-05	101
LOKIASV2_0914_ESMFold_hypothetical_protein	6ae3-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6ae3-assembly2.cif.gz_D Crystal structure of GSK3beta complexed with Morin	0.141	215	173	53	267	21	222	9.377E-05	101
LOKIASV2_0914_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.128	215	186	53	267	22	235	2.892E-05	101
LOKIASV2_0914_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B Binary complex structure of human tau protein kinase I with AMPPNP	0.128	215	186	53	267	34	247	3.421E-05	101
LOKIASV2_0914_ESMFold_hypothetical_protein	5u7q-assembly6.cif.gz_D-3	LOKIASV2_0914_ESMFold_hypothetical_protein	5u7q-assembly6.cif.gz_D-3 Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	0.138	313	255	3	299	25	337	1.468E-04	101
LOKIASV2_0914_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	0.144	272	229	3	274	25	293	6.700E-05	101
LOKIASV2_0914_ESMFold_hypothetical_protein	4wbo-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4wbo-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.135	239	195	51	277	158	396	2.067E-05	101
LOKIASV2_0914_ESMFold_hypothetical_protein	2a19-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	2a19-assembly1.cif.gz_C PKR kinase domain- eIF2alpha- AMP-PNP complex.	0.115	237	173	50	286	8	203	4.500E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.131	229	183	55	283	9	220	1.166E-03	100
LOKIASV2_0914_ESMFold_hypothetical_protein	4uyn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4uyn-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.128	226	194	55	277	10	235	4.255E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	0.098	237	205	56	283	14	250	2.172E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.144	240	190	55	277	16	255	5.323E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	2a19-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2a19-assembly1.cif.gz_B PKR kinase domain- eIF2alpha- AMP-PNP complex.	0.114	255	206	50	282	9	263	2.718E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	6in4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6in4-assembly1.cif.gz_A Crystal structure of apo DAPK1 in the presence of 18-crown-6	0.138	239	198	53	283	11	249	2.054E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	7que-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7que-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CKJB68	0.130	222	189	59	276	19	240	2.172E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	8ie5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8ie5-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with oxyresveratrol	0.112	252	211	53	304	11	249	2.172E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B Crystal structure of the human cyclin G associated kinase (GAK)	0.129	240	199	55	284	16	255	4.500E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	4zjj-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4zjj-assembly2.cif.gz_B PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide	0.132	236	184	51	286	18	230	1.173E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	0.134	272	214	55	302	11	282	1.109E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	0.101	269	225	59	309	17	285	2.186E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	6lxy-assembly4.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	6lxy-assembly4.cif.gz_E IRAK4 in complex with inhibitor	0.110	281	211	43	280	6	286	2.172E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289A and S308A mutations	0.129	288	219	53	304	9	296	1.312E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 29	0.107	259	217	55	298	37	295	5.064E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan	0.130	228	192	52	279	18	239	2.067E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitor	0.122	268	219	51	300	24	291	2.054E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	7q4a-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7q4a-assembly1.cif.gz_A Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib	0.125	229	196	59	283	27	255	5.664E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A The MAP kinase JNK3 as target for halogen bonding	0.143	243	201	52	294	18	253	4.788E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	7e11-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7e11-assembly1.cif.gz_A Crystal structure of PKAc-PLN R9C complex	0.124	295	242	28	304	2	296	1.388E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	4xj0-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4xj0-assembly2.cif.gz_B Crystal structure of ERK2 in complex with an inhibitor 14K	0.130	263	217	52	301	13	275	5.356E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_B GSK-3 Beta complexed with Indirubin-3'-monoxime	0.136	215	179	53	267	22	229	9.917E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A PKA in complex with a benzothiophene fragment compound.	0.141	242	205	26	265	4	245	3.215E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E Crystal Structure of Glu208Ala mutant of catalytic subunit of cAMP-dependent protein kinase	0.133	294	234	16	286	2	295	1.642E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	6c9h-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6c9h-assembly1.cif.gz_A non-phosphorylated AMP-activated protein kinase bound to pharmacological activator R734	0.131	251	204	51	301	6	241	2.875E-04	100
LOKIASV2_0914_ESMFold_hypothetical_protein	7k7z-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7k7z-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.106	374	257	27	314	130	503	5.356E-05	100
LOKIASV2_0914_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B Structure of Mnk1 in complex with DS12881479	0.121	230	179	50	279	4	208	3.999E-03	99
LOKIASV2_0914_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK1141	0.118	233	198	55	279	8	240	9.917E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	2x8i-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2x8i-assembly1.cif.gz_A Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration	0.127	233	191	59	278	13	245	1.241E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.138	241	186	59	275	16	256	5.064E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	5jzn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5jzn-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with NVP-TAE684	0.143	251	192	55	279	13	263	3.401E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	2qkr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2qkr-assembly1.cif.gz_A Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound	0.131	187	146	54	240	7	175	2.430E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	7b8w-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7b8w-assembly3.cif.gz_C Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.119	257	212	56	297	12	268	7.495E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	8d6c-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8d6c-assembly1.cif.gz_A Crystal Structure of Human Myt1 Kinase domain Bounded with compound 28	0.092	243	210	55	286	29	271	2.718E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	0.140	249	191	55	277	8	256	2.570E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	8fko-assembly3.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	8fko-assembly3.cif.gz_D Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.142	189	157	53	241	12	195	8.813E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_C Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.120	276	220	51	301	12	287	3.040E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6pxn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6pxn-assembly1.cif.gz_A Human Casein Kinase 1 delta Tau mutant (R178C)	0.140	275	221	51	308	5	279	2.586E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	0.129	294	225	50	308	9	302	2.172E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	4y85-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4y85-assembly2.cif.gz_B Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.109	245	217	53	297	55	298	1.848E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	3zh8-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3zh8-assembly2.cif.gz_B A novel small molecule aPKC inhibitor	0.128	247	204	55	301	8	242	1.468E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	0.136	294	223	50	308	4	297	6.335E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	0.114	252	198	55	278	34	285	8.866E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A PKA double mutant model of PKB in complex with MgATP	0.131	263	220	29	282	2	264	2.570E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	0.111	308	218	52	297	13	320	1.477E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6eq9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6eq9-assembly1.cif.gz_A Crystal structure of JNK3 in complex with AMP-PCP	0.137	232	196	52	279	18	249	6.335E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	3ncz-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3ncz-assembly1.cif.gz_B X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	0.142	283	220	4	286	33	289	2.298E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2 MRCK beta in complex with BDP00005290	0.127	278	228	26	287	51	328	1.642E-04	99
LOKIASV2_0914_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A Crystal Structure and Allosteric Activation of Protein Kinase C beta II	0.122	216	185	59	274	201	412	7.086E-05	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B Crystal structure of STING CTD in complex with TBK1	0.130	158	130	59	216	17	166	1.543E-03	99
LOKIASV2_0914_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	0.124	231	196	55	279	8	238	5.630E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	7o2v-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7o2v-assembly1.cif.gz_A AURORA KINASE A IN COMPLEX WITH THE AUR-A/PDK1 INHIBITOR VI8	0.126	233	193	55	276	18	250	4.023E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	0.149	246	191	56	301	19	244	1.173E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	4acm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4acm-assembly1.cif.gz_A CDK2 IN COMPLEX WITH 3-AMINO-6-(4-{[2-(DIMETHYLAMINO)ETHYL]SULFAMOYL}-PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE	0.132	200	163	55	254	5	193	1.942E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.140	248	198	55	285	10	257	1.468E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	4fkq-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fkq-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with oxindole inhibitor	0.152	200	165	55	254	5	199	2.718E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	6ti8-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6ti8-assembly3.cif.gz_C IRAK4 IN COMPLEX WITH inhibitor	0.115	270	205	50	282	15	284	2.054E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	5iey-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5iey-assembly1.cif.gz_A Crystal structure of a CDK inhibitor bound to CDK2	0.152	204	170	51	254	2	202	1.942E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1	0.132	217	179	51	267	2	208	2.172E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A Structure of CDK2 in complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine.	0.119	213	175	55	267	6	205	3.215E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	7s47-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7s47-assembly1.cif.gz_A Integrin beta5(743-774)-linker-PAK4cat(D440N/S474E)	0.131	271	201	50	281	19	289	9.377E-05	98
LOKIASV2_0914_ESMFold_hypothetical_protein	5yt3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5yt3-assembly1.cif.gz_A Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant	0.129	252	211	23	274	2	244	1.942E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	4y85-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4y85-assembly1.cif.gz_A Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.112	245	216	53	297	56	299	3.059E-05	98
LOKIASV2_0914_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.136	281	222	29	286	2	282	7.086E-05	98
LOKIASV2_0914_ESMFold_hypothetical_protein	4crs-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4crs-assembly1.cif.gz_A Human Protein Kinase N2 (PKN2, PRKCL2) in complex with ATPgammaS	0.110	243	205	59	301	19	249	2.718E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A PKAB3 in complex with pyrrolidine inhibitor 34a	0.123	265	216	51	297	28	292	4.023E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	3fhi-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3fhi-assembly1.cif.gz_A Crystal structure of a complex between the catalytic and regulatory (RI{alpha}) subunits of PKA	0.139	296	238	28	304	2	297	6.335E-05	98
LOKIASV2_0914_ESMFold_hypothetical_protein	6y7y-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6y7y-assembly1.cif.gz_A Fragments KCL_771 and KCL_802 in complex with MAP kinase p38-alpha	0.131	237	199	52	288	18	247	5.664E-05	98
LOKIASV2_0914_ESMFold_hypothetical_protein	3q3b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3q3b-assembly1.cif.gz_A 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors	0.130	258	216	53	301	22	279	2.586E-05	98
LOKIASV2_0914_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.127	222	166	51	241	24	245	1.388E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	2vd5-assembly2.cif.gz_B-3	LOKIASV2_0914_ESMFold_hypothetical_protein	2vd5-assembly2.cif.gz_B-3 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.129	295	238	26	299	34	328	1.049E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	0.140	308	255	3	299	27	334	1.312E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	7p6n-assembly3.cif.gz_E-4	LOKIASV2_0914_ESMFold_hypothetical_protein	7p6n-assembly3.cif.gz_E-4 ROCK2 IN COMPLEX WITH COMPOUND 12	0.142	310	254	3	299	29	338	1.312E-04	98
LOKIASV2_0914_ESMFold_hypothetical_protein	7jou-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	7jou-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK1) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.148	296	233	26	299	41	336	6.335E-05	98
LOKIASV2_0914_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	0.138	243	197	56	298	11	240	2.298E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B Crystal structure of Nek7 SRS mutant bound to compound 51	0.144	251	213	56	306	17	266	2.054E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	7eec-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7eec-assembly1.cif.gz_A Crystal structure of EphA7 mutant G656R	0.125	256	218	51	306	25	274	2.875E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	6jgm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6jgm-assembly1.cif.gz_A Crystal structure of CDK2 IN complex with Inhibitor NU-6140	0.147	214	165	54	267	2	196	1.241E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	1ke9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1ke9-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	0.152	217	166	51	267	2	198	9.377E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	4bc6-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4bc6-assembly1.cif.gz_A-2 Crystal structure of human serine threonine kinase-10 bound to novel Bosutinib Isoform 1, previously thought to be Bosutinib	0.146	268	214	55	306	14	281	2.172E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	6t6f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6t6f-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 8 (CS275)	0.156	241	197	51	285	10	250	3.040E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	6cqd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6cqd-assembly1.cif.gz_A Crystal structure of HPK1 in complex with ATP analogue (AMPPNP)	0.120	273	219	53	302	15	287	3.401E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	6q4h-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6q4h-assembly1.cif.gz_A CDK2 in complex with FragLite36	0.133	215	176	53	267	5	208	2.570E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	6yat-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6yat-assembly1.cif.gz_A Crystal structure of STK4 (MST1) in complex with compound 6	0.145	278	223	52	313	12	289	2.430E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.140	251	190	55	305	5	226	8.383E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	4y85-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4y85-assembly3.cif.gz_C Crystal structure of COT kinase domain in complex with 5-(5-(1H-indol-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine	0.109	245	215	53	297	54	295	2.312E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	4d2w-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4d2w-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	0.141	239	192	45	283	5	229	9.917E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B Crystal Structure of CK2alpha with Compound 3 bound	0.106	258	220	55	301	37	294	7.927E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	LOKIASV2_0914_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	0.151	261	210	55	302	13	273	1.109E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine bound	0.118	261	217	55	301	38	298	6.700E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	1ian-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1ian-assembly1.cif.gz_A HUMAN P38 MAP KINASE INHIBITOR COMPLEX	0.134	250	213	52	301	19	265	1.652E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	0.115	247	203	55	301	11	240	5.356E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	0.125	255	218	52	301	19	273	1.055E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E Hydrolysis of ATP in the crystal of Y204A mutant of cAMP-dependent protein kinase	0.133	299	242	25	304	3	301	1.642E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.127	273	205	51	286	24	296	1.848E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.121	257	205	56	289	16	272	5.064E-05	97
LOKIASV2_0914_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	0.141	293	251	7	299	34	326	1.942E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	0.109	254	205	55	285	523	776	5.954E-04	97
LOKIASV2_0914_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.128	230	194	50	279	9	231	5.323E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.100	235	207	53	283	9	243	2.172E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D Aurora A inhibitor complex	0.140	238	193	55	279	9	246	1.942E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.128	252	213	55	306	16	260	1.642E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873	0.127	213	163	55	267	5	192	1.468E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	3eh9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3eh9-assembly1.cif.gz_A Crystal structure of death associated protein kinase complexed with ADP	0.118	265	210	53	291	11	275	3.401E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	4use-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4use-assembly1.cif.gz_A Human STK10 (LOK) with SB-633825	0.149	269	214	55	306	14	282	1.049E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	5xvu-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5xvu-assembly3.cif.gz_C Crystal structure of the protein kinase CK2 catalytic domain from Plasmodium falciparum bound to ATP	0.122	266	216	55	301	33	298	7.927E-05	96
LOKIASV2_0914_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A Protein kinase A fivefold mutant model of Rho-kinase with Y-27632	0.127	297	236	30	300	3	299	2.172E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.130	215	184	53	267	22	233	8.866E-05	96
LOKIASV2_0914_ESMFold_hypothetical_protein	4pte-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4pte-assembly1.cif.gz_B Structure of a carvoxamide compound (15) (N-[4-(ISOQUINOLIN-7-YL)PYRIDIN-2-YL]CYCLOPROPANECARBOXAMIDE) to GSK3b	0.125	238	207	53	289	21	258	5.356E-05	96
LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	0.095	267	203	59	283	19	285	4.281E-05	96
LOKIASV2_0914_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.093	293	207	56	284	62	354	1.049E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	0.138	267	216	26	276	51	317	2.172E-04	96
LOKIASV2_0914_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.133	227	195	55	281	11	236	5.323E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	2y4p-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	2y4p-assembly1.cif.gz_C Dimeric structure of DAPK-1 catalytic domain	0.124	249	198	53	279	11	259	3.215E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_B Structure of Aurora Kinase A in complex with activator peptide	0.123	251	208	42	279	6	256	1.736E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	0.140	251	213	56	306	17	265	3.804E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	5bvw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5bvw-assembly1.cif.gz_A Fragment-based discovery of potent and selective DDR1/2 inhibitors	0.115	238	196	55	276	8	245	1.241E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	4lg4-assembly6.cif.gz_F	LOKIASV2_0914_ESMFold_hypothetical_protein	4lg4-assembly6.cif.gz_F Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.132	266	229	52	317	9	273	1.942E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	3f5g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3f5g-assembly1.cif.gz_A Crystal structure of death associated protein kinase in complex with ADP and Mg2+	0.114	266	211	53	291	11	276	3.401E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	0.132	217	170	51	267	2	198	1.942E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	5nk3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5nk3-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1l	0.142	259	215	55	305	14	272	2.298E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	6thw-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6thw-assembly2.cif.gz_B IRAK4 in complex with inhibitor	0.112	253	218	59	304	28	280	2.298E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	4anb-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4anb-assembly1.cif.gz_A Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.	0.158	220	184	55	274	12	230	2.054E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly4.cif.gz_D Human STK10 bound to a maleimide inhibitor	0.124	276	223	50	305	11	286	5.323E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	6tsz-assembly1.cif.gz_U	LOKIASV2_0914_ESMFold_hypothetical_protein	6tsz-assembly1.cif.gz_U The ULK4 Pseudokinase Domain Bound To ATPgammaS	0.125	228	190	55	272	9	236	2.298E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	0.123	288	220	53	304	10	297	3.040E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	2x0g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2x0g-assembly1.cif.gz_A X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX	0.136	299	226	53	315	10	308	3.597E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	3bv2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3bv2-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30	0.108	258	223	51	301	18	275	5.990E-05	95
LOKIASV2_0914_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp117	0.125	301	242	27	304	1	301	2.172E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G4998	0.119	280	241	26	299	43	322	1.312E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.130	294	238	26	299	44	337	2.570E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	7myj-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7myj-assembly2.cif.gz_C Structure of full length human AMPK (a2b1g1) in complex with a small molecule activator MSG011	0.129	316	224	56	313	11	326	2.298E-04	95
LOKIASV2_0914_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A Crystal structure of Mnk1 catalytic domain	0.116	237	208	50	285	6	242	2.554E-03	94
LOKIASV2_0914_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136N double mutant	0.103	230	204	56	283	13	242	5.630E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.104	239	206	53	283	8	246	8.333E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	6u5l-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6u5l-assembly1.cif.gz_A Structure of human ULK4 in complex with an inhibitor	0.115	247	217	55	301	7	252	2.875E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	6ul8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6ul8-assembly1.cif.gz_A RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide	0.135	254	218	51	303	12	265	3.597E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	6q3b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6q3b-assembly1.cif.gz_A CDK2 in complex with FragLite2	0.146	209	163	59	267	9	200	1.388E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.125	266	201	55	285	9	274	1.109E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT	0.120	290	223	53	306	8	297	1.312E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	1tki-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1tki-assembly1.cif.gz_A AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN	0.120	277	213	55	297	8	284	5.630E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.129	294	236	29	300	2	295	8.866E-05	94
LOKIASV2_0914_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	0.117	266	217	55	301	53	318	1.312E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A SRPK1 in complex with Alectinib	0.121	266	197	59	283	19	284	1.942E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	0.129	228	165	51	241	23	250	1.552E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_B Crystal Structure of PF11_0147	0.149	257	203	51	289	10	266	1.552E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	3vwa-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3vwa-assembly1.cif.gz_A Crystal structure of Cex1p	0.107	234	195	53	286	15	233	4.255E-04	94
LOKIASV2_0914_ESMFold_hypothetical_protein	4yzm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4yzm-assembly1.cif.gz_A Humanized Roco4 bound to LRRK2-In1	0.122	249	198	55	280	11	259	1.166E-03	93
LOKIASV2_0914_ESMFold_hypothetical_protein	3bhy-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3bhy-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with a beta-carboline ligand	0.118	262	206	55	289	7	268	5.954E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives	0.113	265	206	55	287	7	271	2.172E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A Co-crystal structure of Checkpoint Kinase Chk1 with a pyrrolo-pyridine inhibitor	0.114	262	207	55	289	8	269	3.215E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	4bgh-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bgh-assembly1.cif.gz_A Crystal Structure of CDK2 in complex with pan-CDK Inhibitor	0.145	209	156	59	267	9	192	1.552E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	4zji-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4zji-assembly4.cif.gz_D PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.130	263	216	51	299	16	278	1.173E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	0.125	271	216	55	302	12	282	5.630E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.125	271	216	53	300	12	282	9.857E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	5vcw-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5vcw-assembly2.cif.gz_B CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Pelitinib	0.094	243	206	59	286	39	281	3.215E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.108	277	223	51	301	12	288	2.430E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	1wmk-assembly4.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1wmk-assembly4.cif.gz_B Human death-associated kinase DRP-1, mutant S308D d40	0.133	292	221	53	308	11	302	3.215E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	5zn1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5zn1-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit in D2O	0.120	266	216	55	301	38	303	2.430E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp017 and RKp117	0.133	294	236	28	300	2	295	2.298E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	0.127	255	218	51	301	19	273	4.788E-05	93
LOKIASV2_0914_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SAR Studies	0.135	294	234	29	300	2	295	1.942E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	5eko-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5eko-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.128	258	218	51	301	22	279	1.642E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	4yno-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4yno-assembly1.cif.gz_A Crystal structure of MAPK13 at INACTIVE FORM	0.132	259	217	51	301	22	280	1.241E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G4998	0.141	284	235	26	299	37	320	8.383E-05	93
LOKIASV2_0914_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G5018	0.143	294	250	7	299	32	325	1.736E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	0.138	294	233	4	297	31	301	3.215E-04	93
LOKIASV2_0914_ESMFold_hypothetical_protein	6d3l-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6d3l-assembly1.cif.gz_A Crystal structure of unphosphorylated human PKR	0.136	239	201	53	286	10	248	3.804E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	5oq6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5oq6-assembly1.cif.gz_A Structure of CHK1 12-pt. mutant complex with aminopyrimido-benzodiazepinone LRRK2 inhibitor	0.151	245	194	55	284	6	250	3.215E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	2j90-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2j90-assembly1.cif.gz_A Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)	0.117	228	195	55	276	10	237	8.813E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 1)	0.123	224	188	55	278	3	217	2.172E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	5auu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5auu-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with luteolin.	0.121	260	205	53	286	11	270	2.875E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.126	227	195	50	276	9	232	5.323E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	8fko-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8fko-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.127	270	218	50	300	10	279	1.103E-03	92
LOKIASV2_0914_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	0.107	274	220	55	301	11	284	2.875E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	0.120	274	220	56	306	6	279	3.040E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	4zy5-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4zy5-assembly2.cif.gz_B Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17	0.125	272	218	50	299	13	284	2.430E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	6n8g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6n8g-assembly1.cif.gz_A IRAK4 bound to benzoxazole compound	0.129	280	206	43	280	6	285	6.660E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	6q4i-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6q4i-assembly1.cif.gz_A CDK2 in complex with FragLite35	0.125	209	172	59	267	9	205	3.597E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	2c6o-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2c6o-assembly1.cif.gz_A Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor	0.130	213	177	55	267	5	209	2.875E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	2bak-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2bak-assembly1.cif.gz_A p38alpha MAP kinase bound to MPAQ	0.124	243	207	52	294	19	255	6.335E-05	92
LOKIASV2_0914_ESMFold_hypothetical_protein	3coi-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3coi-assembly1.cif.gz_A Crystal structure of p38delta kinase	0.127	259	218	51	301	24	282	1.942E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-(trifluoromethyl)benzenecarboximidamide	0.132	295	234	27	297	11	305	5.323E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	0.130	295	235	27	297	12	306	2.718E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp190	0.129	307	239	23	297	2	308	6.660E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.094	282	206	56	283	62	343	4.255E-04	92
LOKIASV2_0914_ESMFold_hypothetical_protein	2ym4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2ym4-assembly1.cif.gz_A Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors	0.131	233	196	52	278	2	234	2.718E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_C TRK-A IN COMPLEX WITH LIGAND	0.107	256	224	55	306	12	267	2.570E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain bound to AppCp from D. discoideum	0.114	260	203	55	284	11	270	9.320E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	5w84-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5w84-assembly1.cif.gz_A CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)	0.120	255	196	59	282	27	281	4.023E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	6ti8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6ti8-assembly1.cif.gz_A IRAK4 IN COMPLEX WITH inhibitor	0.109	257	199	59	282	27	283	1.942E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	0.121	281	224	51	306	4	284	2.570E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	4ptg-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4ptg-assembly2.cif.gz_B Structure of a carboxamine compound (26) (2-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}-4-METHOXYPYRIMIDINE-5-CARBOXAMIDE) to GSK3b	0.146	249	212	53	301	20	268	8.383E-05	91
LOKIASV2_0914_ESMFold_hypothetical_protein	4eyj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4eyj-assembly1.cif.gz_A MAPK13 Complex with inhibitor	0.118	255	221	51	301	22	276	1.312E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	0.118	261	200	59	286	17	277	1.642E-04	91
LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	0.098	268	202	59	283	19	286	6.335E-05	91
LOKIASV2_0914_ESMFold_hypothetical_protein	4nm5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4nm5-assembly1.cif.gz_A Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 c-motif	0.135	239	203	53	288	33	271	9.377E-05	91
LOKIASV2_0914_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	0.136	223	190	55	277	9	229	1.379E-03	90
LOKIASV2_0914_ESMFold_hypothetical_protein	1zy4-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1zy4-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: R794G Hyperactivating Mutant in Apo Form.	0.139	235	183	50	284	5	217	3.804E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.130	235	203	50	283	5	239	3.040E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	0.135	256	202	53	286	13	268	1.836E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	5auw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5auw-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with quercetin.	0.143	248	197	53	283	11	258	5.630E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A Structure of PIM-1 kinase bound to 5-(4-cyanobenzyl)-N-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide	0.101	253	204	50	277	4	256	5.954E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	0.121	260	226	49	306	17	276	1.379E-03	90
LOKIASV2_0914_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor	0.141	246	204	56	301	17	254	2.430E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.141	232	191	53	284	3	225	5.033E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	7qg3-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7qg3-assembly2.cif.gz_B IRAK4 in complex with inhibitor	0.105	276	218	36	280	6	281	5.323E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	1oir-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1oir-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	0.131	217	177	51	267	2	206	1.942E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	5sau-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5sau-assembly1.cif.gz_A DDR1, 3-[2-(6-aminopyridin-3-yl)ethynyl]-N-[3-(trifluoromethyl)phenyl]benzamide, 1.800A, P212121, Rfree=23.1%	0.117	249	197	53	276	9	257	5.664E-05	90
LOKIASV2_0914_ESMFold_hypothetical_protein	4yp8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4yp8-assembly1.cif.gz_A Irak4-inhibitor co-structure	0.111	257	196	59	280	28	284	6.660E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	6uya-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6uya-assembly1.cif.gz_B Crystal structure of Compound 19 bound to IRAK4	0.114	284	210	43	280	5	288	6.297E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	2xzs-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2xzs-assembly2.cif.gz_B Death associated protein kinase 1 residues 1-312	0.102	252	213	53	304	9	246	3.040E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	4uv0-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4uv0-assembly1.cif.gz_A Structure of a semisynthetic phosphorylated DAPK	0.125	290	221	53	306	10	299	7.044E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.098	291	205	51	278	5	295	4.759E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor	0.128	248	199	52	299	19	247	1.736E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	7pie-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7pie-assembly1.cif.gz_A Protein kinase A catalytic subunit in complex with PKI5-24 and EN068	0.132	307	238	23	297	2	308	4.500E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	3i4b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3i4b-assembly1.cif.gz_A Crystal structure of GSK3b in complex with a pyrimidylpyrrole inhibitor	0.138	239	203	53	291	30	266	7.086E-05	90
LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G4998	0.136	290	236	26	299	42	331	1.388E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.119	315	239	28	299	21	335	1.552E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	4pnk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4pnk-assembly1.cif.gz_A G protein-coupled receptor kinase 2 in complex with GSK180736A	0.101	387	271	13	314	117	503	4.759E-04	90
LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.112	224	195	55	278	9	229	7.450E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain.	0.126	231	197	59	289	20	245	5.323E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B Aurora-A Inhibitor Structure	0.124	246	196	55	279	9	254	1.043E-03	89
LOKIASV2_0914_ESMFold_hypothetical_protein	5de2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5de2-assembly1.cif.gz_A Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.146	250	212	56	304	17	266	4.500E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A Crystal structure of CHK1 kinase domain in complex with a CLASPIN phosphopeptide	0.126	265	209	50	289	5	269	7.044E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.116	246	199	55	280	21	266	1.642E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	8bfs-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8bfs-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ326	0.160	236	195	50	282	9	244	4.759E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	7ats-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7ats-assembly1.cif.gz_A The LIMK1 Kinase Domain Bound To LIJTF500127	0.131	253	210	55	297	13	265	2.718E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	3dgk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3dgk-assembly1.cif.gz_A Crystal structure of a glycine-rich loop mutant of the death associated protein kinase catalytic domain	0.125	252	213	53	304	11	254	6.297E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	4fg9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fg9-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.147	232	196	50	281	8	238	8.333E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	6fu5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6fu5-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18	0.120	269	220	51	301	12	280	4.023E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	0.124	262	215	56	302	19	280	7.879E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly3.cif.gz_C Human STK10 bound to a maleimide inhibitor	0.120	278	224	50	305	10	287	3.804E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.122	277	219	53	302	10	286	7.044E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	5vi9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5vi9-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitors	0.137	285	231	29	297	2	286	2.718E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	0.096	265	205	59	286	17	281	2.875E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alpha	0.132	258	216	52	301	18	275	1.049E-04	89
LOKIASV2_0914_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.109	232	200	55	286	22	246	1.632E-03	89
LOKIASV2_0914_ESMFold_hypothetical_protein	2iwi-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2iwi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1	0.101	234	199	56	277	3	236	1.379E-03	88
LOKIASV2_0914_ESMFold_hypothetical_protein	5owq-assembly3.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5owq-assembly3.cif.gz_A Human STK10 bound to dovitinib	0.137	252	209	55	306	8	250	8.333E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	7jw7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7jw7-assembly1.cif.gz_A Structure of monobody 27 human MLKL pseudokinase domain complex	0.113	223	185	50	272	8	217	1.103E-03	88
LOKIASV2_0914_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A Crystal Structure of Pim-1 Kinase in complex with inhibitor (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4-one	0.114	246	197	55	277	3	248	8.333E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	0.102	265	208	50	282	3	267	1.379E-03	88
LOKIASV2_0914_ESMFold_hypothetical_protein	5nxc-assembly1.cif.gz_L	LOKIASV2_0914_ESMFold_hypothetical_protein	5nxc-assembly1.cif.gz_L LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736	0.125	220	179	55	274	13	217	4.500E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_A Crystal Structure of the Human Ribosomal protein S6 kinase	0.104	272	224	56	306	5	276	7.044E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	6thz-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6thz-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	0.113	254	196	59	280	28	281	5.323E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	6mom-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6mom-assembly3.cif.gz_C Crystal structure of human Interleukin-1 receptor associated Kinase 4 (IRAK 4, CID 100300) in complex with compound NCC00371481 (BSI 107591)	0.125	260	193	59	280	29	288	5.323E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	6cth-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6cth-assembly1.cif.gz_A Crystal Structure of Pathogenesis-related Protein 1G (PR-1G) Kinase Domain from Cacao	0.104	268	206	59	289	21	288	1.379E-03	88
LOKIASV2_0914_ESMFold_hypothetical_protein	3new-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3new-assembly1.cif.gz_A p38-alpha complexed with Compound 10	0.137	243	205	52	294	19	256	7.086E-05	88
LOKIASV2_0914_ESMFold_hypothetical_protein	5f95-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5f95-assembly2.cif.gz_B Crystal structure of GSK3b in complex with Compound 18: 2-[(cyclopropylcarbonyl)amino]-N-(4-phenylpyridin-3-yl)pyridine-4-carboxamide	0.136	254	214	53	301	21	274	1.312E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	0.123	266	196	59	283	19	284	7.495E-05	88
LOKIASV2_0914_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	0.135	267	194	59	283	19	285	7.927E-05	88
LOKIASV2_0914_ESMFold_hypothetical_protein	5xzv-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5xzv-assembly2.cif.gz_B Crystal structure of Rad53 1-466 in complex with AMP-PNP	0.131	256	207	42	280	113	368	1.379E-03	88
LOKIASV2_0914_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B Structure of J-PKAc chimera complexed with Aplithianine A	0.120	300	240	28	301	63	362	6.297E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	4e3c-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4e3c-assembly2.cif.gz_B X-ray crystal structure of human IKK2 in an active conformation	0.132	223	174	55	256	1	223	1.388E-04	88
LOKIASV2_0914_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.124	238	196	55	279	8	245	1.825E-03	87
LOKIASV2_0914_ESMFold_hypothetical_protein	8p4z-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8p4z-assembly1.cif.gz_A Crystal structure of the human CDK7 kinase domain in complex with LDC4297	0.145	208	153	60	267	8	187	6.335E-05	87
LOKIASV2_0914_ESMFold_hypothetical_protein	1yrp-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1yrp-assembly1.cif.gz_B Catalytic domain of human ZIP kinase phosphorylated at Thr265	0.125	241	200	50	290	9	237	1.379E-03	87
LOKIASV2_0914_ESMFold_hypothetical_protein	3gu6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3gu6-assembly1.cif.gz_A Crystal structure of DAPKQ23V-ADP	0.139	250	198	53	283	11	260	9.857E-04	87
LOKIASV2_0914_ESMFold_hypothetical_protein	1h07-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1h07-assembly1.cif.gz_A CDK2 in complex with a disubstituted 4, 6-bis anilino pyrimidine CDK4 inhibitor	0.137	213	172	55	267	5	204	1.468E-04	87
LOKIASV2_0914_ESMFold_hypothetical_protein	6vql-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6vql-assembly1.cif.gz_D CRYSTAL STRUCTURE OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4-WT) COMPLEX WITH A NICOTINAMIDE INHIBITOR	0.116	280	210	43	280	6	285	1.304E-03	87
LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly1.cif.gz_B Human STK10 bound to a maleimide inhibitor	0.129	280	222	51	306	10	289	7.450E-04	87
LOKIASV2_0914_ESMFold_hypothetical_protein	6bfn-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6bfn-assembly2.cif.gz_B Crystal structure of human IRAK1	0.150	205	143	59	263	24	192	1.931E-03	87
LOKIASV2_0914_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	0.130	203	172	55	253	10	212	2.875E-04	87
LOKIASV2_0914_ESMFold_hypothetical_protein	5iu2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5iu2-assembly1.cif.gz_A Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious COT kinase inhibitors	0.132	243	208	55	297	65	305	2.054E-04	87
LOKIASV2_0914_ESMFold_hypothetical_protein	3lff-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3lff-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL166	0.120	254	219	52	301	19	272	1.173E-04	87
LOKIASV2_0914_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.117	252	220	52	301	23	274	1.836E-04	87
LOKIASV2_0914_ESMFold_hypothetical_protein	7q4a-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7q4a-assembly1.cif.gz_B Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib	0.116	291	217	59	304	28	318	5.990E-05	87
LOKIASV2_0914_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A The crystal structure of human aurka kinase domain in complex with AURKA-A2	0.141	225	191	55	277	8	232	1.103E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.155	232	185	52	283	7	226	2.284E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	0.135	222	180	51	272	5	213	1.304E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A Aurora-A in complex with TACC3	0.125	250	205	55	289	9	258	1.103E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D Crystal structure of Nek7 SRS mutant bound to compound 51	0.132	256	214	51	306	10	257	9.857E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.120	245	201	51	279	9	253	1.543E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	3rak-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3rak-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-32	0.124	217	168	51	267	2	194	1.043E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	3gub-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3gub-assembly1.cif.gz_A Crystal structure of DAPKL93G complexed with N6-(2-Phenylethyl)adenosine	0.119	238	199	53	290	11	237	1.379E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	2vv9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2vv9-assembly1.cif.gz_A CDK2 in complex with an imidazole piperazine	0.135	213	165	55	267	5	196	4.759E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	6vql-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6vql-assembly1.cif.gz_B CRYSTAL STRUCTURE OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4-WT) COMPLEX WITH A NICOTINAMIDE INHIBITOR	0.125	256	193	59	280	29	284	1.233E-03	86
LOKIASV2_0914_ESMFold_hypothetical_protein	4ztn-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4ztn-assembly3.cif.gz_C Irak4-inhibitor co-structure	0.125	255	193	59	279	28	282	6.660E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	2clx-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2clx-assembly1.cif.gz_A 4-Arylazo-3,5-diamino-1H-pyrazole CDK Inhibitors: SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effects	0.132	213	178	55	267	5	210	5.630E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B The crystal structure of CASK/Mint1 complex	0.131	289	219	55	307	9	297	5.630E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340	0.141	262	192	59	283	17	278	9.917E-05	86
LOKIASV2_0914_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-(pyridin-3-yl)ethanamine	0.136	300	239	27	304	6	305	5.954E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	0.135	281	204	52	288	7	287	5.323E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	6sp9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6sp9-assembly1.cif.gz_A Fragment KCL802 in complex with MAP kinase p38-alpha	0.119	260	219	52	301	19	278	1.388E-04	86
LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.109	250	210	55	304	8	244	7.044E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.109	250	209	55	304	8	243	6.660E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	1zy5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zy5-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: R794G Hyperactivating Mutant Complexed with AMPPNP.	0.141	235	191	50	284	4	226	4.255E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	6szj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6szj-assembly1.cif.gz_A RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide.	0.118	225	191	50	274	11	228	3.999E-03	85
LOKIASV2_0914_ESMFold_hypothetical_protein	1di8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1di8-assembly1.cif.gz_A THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE	0.149	256	197	51	283	2	257	2.718E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	6szj-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6szj-assembly1.cif.gz_B RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide.	0.106	271	226	51	304	12	282	3.196E-03	85
LOKIASV2_0914_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	0.133	216	178	52	267	2	207	1.043E-03	85
LOKIASV2_0914_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.134	256	203	56	290	5	260	3.401E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	7juy-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	7juy-assembly1.cif.gz_C Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib	0.134	290	235	34	305	5	294	1.552E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	4eym-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4eym-assembly1.cif.gz_A MAPK13 complex with inhibitor	0.125	257	219	51	301	22	278	1.468E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	5uoj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5uoj-assembly1.cif.gz_A THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTROMS RESOLUTION	0.128	262	218	51	301	18	279	2.875E-04	85
LOKIASV2_0914_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	0.119	225	196	55	277	9	233	3.999E-03	84
LOKIASV2_0914_ESMFold_hypothetical_protein	3coh-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3coh-assembly2.cif.gz_B Crystal structure of Aurora-A in complex with a pentacyclic inhibitor	0.115	232	198	55	279	7	238	1.543E-03	84
LOKIASV2_0914_ESMFold_hypothetical_protein	2fh9-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	2fh9-assembly1.cif.gz_A-2 Structure and dimerization of the kinase domain from yeast Snf1	0.114	218	175	56	273	12	210	5.033E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	3uiu-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3uiu-assembly2.cif.gz_B Crystal structure of Apo-PKR kinase domain	0.106	245	211	50	286	11	255	9.857E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	0.113	238	200	55	280	10	247	5.033E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B Crystal structure of murine SPAK(T243D) in complex with AMPPNP	0.143	258	212	55	302	11	268	3.401E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D Structure of the OSR1 kinase, a hypertension drug target	0.164	216	161	55	270	13	206	7.450E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly2.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6hxf-assembly2.cif.gz_A Human STK10 bound to a maleimide inhibitor	0.126	275	223	51	306	10	284	2.702E-03	84
LOKIASV2_0914_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A p38alpha bound to novel DGF-out compound PF-00215955	0.139	244	203	51	294	18	254	5.954E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	5r9q-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5r9q-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N07422b in complex with MAP kinase p38-alpha	0.122	265	219	52	301	19	283	2.172E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	0.103	265	201	59	283	19	283	2.570E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.133	288	231	50	317	15	302	5.630E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compound RKp032	0.147	251	209	27	272	12	262	3.804E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_B Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain	0.127	222	185	59	271	15	236	9.857E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	5ukl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ukl-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG222886 (14bd)	0.104	378	258	26	314	128	505	5.630E-04	84
LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.136	232	187	52	283	7	224	7.450E-04	83
LOKIASV2_0914_ESMFold_hypothetical_protein	1zy5-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1zy5-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: R794G Hyperactivating Mutant Complexed with AMPPNP.	0.119	219	178	55	273	9	211	5.323E-04	83
LOKIASV2_0914_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B Crystal structure of M.tuberculosis PknI kinase domain	0.107	235	203	56	283	13	247	1.043E-03	83
LOKIASV2_0914_ESMFold_hypothetical_protein	4fg8-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4fg8-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-315 in complex with ATP	0.141	223	186	53	275	10	226	1.233E-03	83
LOKIASV2_0914_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_B Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	0.114	255	200	55	281	8	262	9.857E-04	83
LOKIASV2_0914_ESMFold_hypothetical_protein	5iex-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5iex-assembly1.cif.gz_A Crystal structure of (R,S)-S-{4-[(5-Bromo-4-{[(2R,3R)-2-hydroxy-1-methylpropyl]oxy}- pyrimidin-2-yl)amino]phenyl}-S-cyclopropylsulfoximide bound to CDK2	0.128	213	172	55	267	5	202	1.043E-03	83
LOKIASV2_0914_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6eim-assembly1.cif.gz_B Human STK10 bound to GW683134A	0.135	281	222	49	306	10	290	1.459E-03	83
LOKIASV2_0914_ESMFold_hypothetical_protein	4ixp-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4ixp-assembly1.cif.gz_A Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK)	0.135	247	208	43	283	2	248	5.033E-04	83
LOKIASV2_0914_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.117	250	206	55	304	22	255	1.304E-03	83
LOKIASV2_0914_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	0.130	243	196	55	297	11	236	5.918E-03	82
LOKIASV2_0914_ESMFold_hypothetical_protein	8s99-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8s99-assembly2.cif.gz_B Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.129	240	194	55	294	12	235	3.022E-03	82
LOKIASV2_0914_ESMFold_hypothetical_protein	4j8m-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4j8m-assembly1.cif.gz_A Aurora A in complex with CD532	0.128	243	194	55	277	10	252	1.543E-03	82
LOKIASV2_0914_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A Humanized Roco4 bound to Compound 19	0.109	260	200	55	280	9	268	1.543E-03	82
LOKIASV2_0914_ESMFold_hypothetical_protein	6t28-assembly1.cif.gz_AAA	LOKIASV2_0914_ESMFold_hypothetical_protein	6t28-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 19 (CS640)	0.161	233	195	50	282	9	241	1.379E-03	82
LOKIASV2_0914_ESMFold_hypothetical_protein	6t29-assembly1.cif.gz_AAA	LOKIASV2_0914_ESMFold_hypothetical_protein	6t29-assembly1.cif.gz_AAA Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 18 (CS587)	0.160	264	213	50	304	9	272	9.857E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	0.115	269	219	55	302	13	281	6.660E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A Human STK10 bound to BIRB-796	0.136	257	217	55	306	22	278	4.500E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	2xuu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2xuu-assembly1.cif.gz_A Crystal structure of a DAP-kinase 1 mutant	0.110	290	225	53	306	11	300	9.857E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	2xzs-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2xzs-assembly1.cif.gz_A Death associated protein kinase 1 residues 1-312	0.132	285	218	53	304	9	293	7.044E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717	0.137	256	215	52	301	19	274	2.430E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	0.118	259	221	51	301	18	276	3.040E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A Fragment N13565a in complex with MAP kinase p38-alpha	0.125	261	218	52	301	19	279	9.377E-05	82
LOKIASV2_0914_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.109	259	200	55	279	8	266	5.033E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	0.114	272	212	50	289	19	290	7.044E-04	82
LOKIASV2_0914_ESMFold_hypothetical_protein	3vwa-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	3vwa-assembly2.cif.gz_B Crystal structure of Cex1p	0.096	246	218	59	300	19	264	1.304E-03	82
LOKIASV2_0914_ESMFold_hypothetical_protein	4pwn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4pwn-assembly1.cif.gz_A Crystal structure of Active WNK1 kinase	0.122	231	189	53	283	13	228	1.931E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	3o51-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3o51-assembly1.cif.gz_A Crystal structure of anthranilamide 10 bound to AuroraA	0.113	232	202	51	279	6	237	3.380E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	4g34-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4g34-assembly1.cif.gz_A Crystal Structure of GSK6924 Bound to PERK (R587-R1092, delete A660-T867) at 2.70 A Resolution	0.129	247	191	55	301	8	227	8.813E-04	81
LOKIASV2_0914_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.121	240	202	50	280	12	251	4.473E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	2ym6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2ym6-assembly1.cif.gz_A Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors	0.115	250	207	55	289	4	253	2.554E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.110	243	198	55	297	8	230	1.103E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	7qg2-assembly4.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	7qg2-assembly4.cif.gz_D IRAK4 in complex with inhibitor	0.113	252	217	59	304	28	279	2.702E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	4at5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4at5-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH GW2580	0.090	270	226	56	304	17	286	2.298E-04	81
LOKIASV2_0914_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.117	279	223	50	302	15	293	1.166E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A The Crystal Structure of PRKACA from Biortus.	0.134	289	231	34	301	2	290	6.297E-04	81
LOKIASV2_0914_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_D Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.124	285	231	50	314	14	298	1.233E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	8x23-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8x23-assembly1.cif.gz_A The Crystal Structure of MAPK13 from Biortus.	0.134	236	191	51	272	23	258	1.379E-03	81
LOKIASV2_0914_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	0.140	245	194	63	289	18	262	5.954E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	8bfm-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	8bfm-assembly1.cif.gz_A-2 Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) in complex with FZ331	0.162	236	194	50	285	9	240	1.931E-03	80
LOKIASV2_0914_ESMFold_hypothetical_protein	2a1a-assembly1.cif.gz_B-2	LOKIASV2_0914_ESMFold_hypothetical_protein	2a1a-assembly1.cif.gz_B-2 PKR kinase domain-eIF2alpha Complex	0.119	257	218	50	298	10	266	8.813E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_B Crystal structure of the V658F apo Jak1 pseudokinase domain	0.131	253	218	55	306	20	272	3.022E-03	80
LOKIASV2_0914_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	0.145	274	203	59	297	15	288	5.033E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A PKA structures of AKT, indazole-pyridine inhibitors	0.123	294	240	30	304	2	295	7.044E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	2baj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2baj-assembly1.cif.gz_A p38alpha bound to pyrazolourea	0.117	253	221	51	301	21	273	3.040E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	0.124	266	218	52	301	19	284	1.312E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	0.103	264	201	59	283	19	282	5.630E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.136	284	231	50	317	9	292	4.023E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	4bwp-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bwp-assembly1.cif.gz_A Structure of Drosophila Melanogaster PAN3 pseudokinase	0.102	268	238	52	317	6	273	7.879E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_A Structure of Neurospora crassa PAN3 pseudokinase mutant	0.101	292	255	26	317	2	286	2.430E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase mutant	0.098	292	260	26	317	2	290	4.500E-04	80
LOKIASV2_0914_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.128	235	187	50	284	5	219	1.726E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	0.147	229	189	55	283	8	229	5.918E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.137	259	219	50	304	4	262	3.380E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	0.131	213	169	55	267	3	198	1.459E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	6tia-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6tia-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	0.106	259	220	59	305	28	286	1.379E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	7l25-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7l25-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 18	0.120	277	219	53	302	11	287	5.323E-04	79
LOKIASV2_0914_ESMFold_hypothetical_protein	3tyk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3tyk-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(4)-Ia	0.086	289	240	41	304	2	290	4.730E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	5yt3-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	5yt3-assembly2.cif.gz_D Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant	0.128	263	219	55	306	31	293	5.954E-04	79
LOKIASV2_0914_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D Crystal Structure of phospholamban (1-19):PKA C-subunit:AMP-PNP:Mg2+ complex	0.147	296	230	28	298	2	297	5.323E-04	79
LOKIASV2_0914_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	0.141	268	213	51	299	29	296	2.554E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	8ahp-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8ahp-assembly1.cif.gz_A The crystal structure of the truncated form of Lotus japonicus kinase 1	0.124	259	211	56	297	34	292	4.759E-04	79
LOKIASV2_0914_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.114	273	207	55	289	7	279	9.857E-04	79
LOKIASV2_0914_ESMFold_hypothetical_protein	4iw0-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4iw0-assembly1.cif.gz_A-2 Crystal structure and mechanism of activation of TBK1	0.103	201	163	59	241	15	215	1.459E-03	79
LOKIASV2_0914_ESMFold_hypothetical_protein	6u2g-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6u2g-assembly1.cif.gz_A BRAF-MEK complex with AMP-PCP bound to BRAF	0.143	261	207	34	276	2	262	5.033E-04	78
LOKIASV2_0914_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A p38 MAP Kinase in Complex with Inhibitor 1	0.120	250	219	52	301	19	268	3.401E-04	78
LOKIASV2_0914_ESMFold_hypothetical_protein	5n65-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5n65-assembly1.cif.gz_A Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9h	0.130	252	217	52	301	19	270	2.718E-04	78
LOKIASV2_0914_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E	LOKIASV2_0914_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE	0.113	294	240	30	301	2	295	1.632E-03	78
LOKIASV2_0914_ESMFold_hypothetical_protein	1yw2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1yw2-assembly1.cif.gz_A Mutated Mus Musculus P38 Kinase (mP38)	0.125	258	218	52	301	20	277	5.954E-04	78
LOKIASV2_0914_ESMFold_hypothetical_protein	6so2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6so2-assembly1.cif.gz_A Fragment N13460a in complex with MAP kinase p38-alpha	0.109	264	220	54	301	19	282	4.500E-04	78
LOKIASV2_0914_ESMFold_hypothetical_protein	6bx6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6bx6-assembly1.cif.gz_A AMP-Activated protein kinase (AMPK) inhibition by SBI-0206965: alpha 2 kinase domain bound to SBI-0206965	0.130	247	183	51	297	2	212	4.730E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	3biz-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3biz-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD331618	0.089	235	208	50	278	4	238	8.759E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.141	219	179	55	273	9	217	2.857E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	6nvi-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6nvi-assembly1.cif.gz_A FGFR4 complex with N-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5-fluorophenyl)acrylamide	0.113	249	199	56	280	17	265	1.459E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 4)	0.120	223	193	55	277	4	223	9.857E-04	77
LOKIASV2_0914_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_A Crystal structure of the V658F apo Jak1 pseudokinase domain	0.107	254	226	55	308	20	273	3.999E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4l00-assembly3.cif.gz_A Crystal structure of the apo Jak1 pseudokinase domain	0.108	238	194	59	277	25	262	3.022E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	3sw7-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3sw7-assembly1.cif.gz_A Crystal Structure of the CDK2 in complex with thiazolylpyrimidine inhibitor	0.124	209	163	59	267	9	195	1.543E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	6vph-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6vph-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 modified with cacodylate and in complex with AMP-PNP	0.134	244	194	55	279	29	272	1.233E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 557	0.138	213	179	59	271	21	229	3.380E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	4eh5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4eh5-assembly1.cif.gz_A Human p38 MAP kinase in complex with NP-F4 and RL87	0.127	243	200	52	294	20	249	1.166E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	3hv5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3hv5-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL24	0.134	257	216	52	301	20	276	2.875E-04	77
LOKIASV2_0914_ESMFold_hypothetical_protein	5r9j-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5r9j-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14231a in complex with MAP kinase p38-alpha	0.124	262	218	52	301	20	281	2.875E-04	77
LOKIASV2_0914_ESMFold_hypothetical_protein	4ysj-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4ysj-assembly1.cif.gz_A Calcium-Dependent Protein Kinase from Eimeria tenella in complex with ADP	0.112	237	204	50	280	18	254	6.259E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	6ygn-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6ygn-assembly1.cif.gz_A Titin kinase and its flanking domains	0.113	244	207	43	286	125	358	2.042E-03	77
LOKIASV2_0914_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A Structure of NEK2 bound to CCT	0.108	238	198	55	277	7	244	3.022E-03	76
LOKIASV2_0914_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	0.137	239	199	55	286	8	246	3.196E-03	76
LOKIASV2_0914_ESMFold_hypothetical_protein	4x7n-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4x7n-assembly1.cif.gz_A Co-crystal Structure of PERK bound to 4-[2-amino-4-methyl-3-(2-methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor	0.125	252	196	50	301	6	230	2.042E-03	76
LOKIASV2_0914_ESMFold_hypothetical_protein	4c8b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4c8b-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with ponatinib	0.134	270	218	51	303	9	278	2.554E-03	76
LOKIASV2_0914_ESMFold_hypothetical_protein	3oef-assembly1.cif.gz_X	LOKIASV2_0914_ESMFold_hypothetical_protein	3oef-assembly1.cif.gz_X Crystal structure of Y323F inactive mutant of p38alpha MAP kinase	0.112	237	197	52	274	19	255	1.233E-03	76
LOKIASV2_0914_ESMFold_hypothetical_protein	5clr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5clr-assembly1.cif.gz_A Crystal structure of LegK4_APO Kinase	0.100	289	239	23	288	20	308	1.233E-03	76
LOKIASV2_0914_ESMFold_hypothetical_protein	6cq5-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6cq5-assembly1.cif.gz_A TBK1 in Complex with Sulfone Analog of Amlexanox	0.133	155	120	59	213	15	153	1.296E-02	76
LOKIASV2_0914_ESMFold_hypothetical_protein	6nvl-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6nvl-assembly2.cif.gz_B FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.113	242	200	59	284	18	259	7.879E-04	75
LOKIASV2_0914_ESMFold_hypothetical_protein	3ma6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3ma6-assembly1.cif.gz_A Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	0.111	264	202	51	278	3	266	3.781E-03	75
LOKIASV2_0914_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 3)	0.112	234	200	55	280	10	243	1.379E-03	75
LOKIASV2_0914_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.135	230	187	55	284	9	225	9.857E-04	75
LOKIASV2_0914_ESMFold_hypothetical_protein	2jc6-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2jc6-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D	0.138	258	221	50	306	10	267	2.857E-03	75
LOKIASV2_0914_ESMFold_hypothetical_protein	4aot-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4aot-assembly2.cif.gz_B Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	0.125	258	220	55	306	20	277	4.730E-03	75
LOKIASV2_0914_ESMFold_hypothetical_protein	8x5l-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	8x5l-assembly2.cif.gz_B The Crystal Structure of PRKACA from Biortus.	0.118	287	235	34	300	2	288	2.042E-03	75
LOKIASV2_0914_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A Co-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor	0.125	247	192	55	301	10	229	2.042E-03	74
LOKIASV2_0914_ESMFold_hypothetical_protein	7atu-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7atu-assembly2.cif.gz_B The LIMK1 Kinase Domain Bound To LIJTF500025	0.113	276	208	55	289	12	287	1.379E-03	74
LOKIASV2_0914_ESMFold_hypothetical_protein	6nvk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6nvk-assembly1.cif.gz_A FGFR4 complex with BLU-554, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide	0.121	246	200	56	301	17	244	9.857E-04	73
LOKIASV2_0914_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	0.141	235	191	55	277	27	261	3.380E-03	73
LOKIASV2_0914_ESMFold_hypothetical_protein	4wun-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4wun-assembly1.cif.gz_A Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE) at 1.65 angstrom	0.101	267	209	56	289	16	282	8.813E-04	73
LOKIASV2_0914_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain bound to ATP	0.126	208	161	53	237	61	268	4.730E-03	73
LOKIASV2_0914_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G	LOKIASV2_0914_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.111	262	204	50	279	4	265	1.931E-03	73
LOKIASV2_0914_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A Co-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide inhibitor	0.131	247	189	55	301	10	228	3.022E-03	72
LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D	LOKIASV2_0914_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	0.141	266	173	7	272	31	232	6.259E-03	72
LOKIASV2_0914_ESMFold_hypothetical_protein	4x7l-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4x7l-assembly1.cif.gz_A Co-crystal Structure of PERK bound to 4-{2-amino-4-methyl-3-[2-(methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor	0.140	247	190	55	301	10	231	2.702E-03	72
LOKIASV2_0914_ESMFold_hypothetical_protein	2oib-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2oib-assembly1.cif.gz_A Crystal structure of IRAK4 kinase domain apo form	0.120	265	202	50	280	17	281	3.196E-03	72
LOKIASV2_0914_ESMFold_hypothetical_protein	4l8m-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4l8m-assembly1.cif.gz_A Human p38 MAP kinase in complex with a Dibenzoxepinone	0.135	259	216	51	301	18	276	7.044E-04	72
LOKIASV2_0914_ESMFold_hypothetical_protein	3u9n-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3u9n-assembly1.cif.gz_A X-ray crystal structure of compound 1 bound to human CHK1 kinase domain	0.120	229	196	55	278	4	232	5.291E-03	71
LOKIASV2_0914_ESMFold_hypothetical_protein	8fjz-assembly3.cif.gz_E-2	LOKIASV2_0914_ESMFold_hypothetical_protein	8fjz-assembly3.cif.gz_E-2 Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.124	270	215	55	301	13	282	4.473E-03	71
LOKIASV2_0914_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	0.110	276	224	50	302	8	283	3.575E-03	71
LOKIASV2_0914_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27	0.088	280	253	24	303	84	361	2.702E-03	71
LOKIASV2_0914_ESMFold_hypothetical_protein	4yur-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4yur-assembly1.cif.gz_A Crystal Structure of Plk4 Kinase Domain Bound to Centrinone	0.117	220	177	55	274	9	210	6.259E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.133	224	193	55	278	9	232	1.825E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	0.126	236	194	55	277	8	243	5.003E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	6s75-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6s75-assembly1.cif.gz_A Crystal structure of Nek7 bound to compound 51	0.119	250	219	55	304	17	266	3.575E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	6jlr-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6jlr-assembly1.cif.gz_A Crystal structure of wild type MNK2 in complex with inhibitor	0.123	249	203	52	283	15	263	5.003E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.133	235	191	50	284	5	225	7.831E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	2w4o-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2w4o-assembly1.cif.gz_A Crystal structure of Human CAMK4 in complex with 4-Amino(sulfamoyl- phenylamino)-triazole-carbothioic acid (2,6-difluoro-phenyl)-amide)	0.103	260	231	50	309	9	266	3.781E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp013	0.146	310	239	23	303	2	311	3.575E-03	70
LOKIASV2_0914_ESMFold_hypothetical_protein	6eh2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6eh2-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp032 and AMP	0.145	294	231	27	297	12	305	5.003E-03	68
LOKIASV2_0914_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib	0.100	280	239	24	303	80	346	4.229E-03	68
LOKIASV2_0914_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE	0.148	227	188	55	276	7	233	3.999E-03	67
LOKIASV2_0914_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.108	269	211	53	289	10	278	4.473E-03	67
LOKIASV2_0914_ESMFold_hypothetical_protein	5r9t-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5r9t-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13477a in complex with MAP kinase p38-alpha	0.119	266	218	54	301	18	283	1.043E-03	67
LOKIASV2_0914_ESMFold_hypothetical_protein	4bwp-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4bwp-assembly1.cif.gz_B Structure of Drosophila Melanogaster PAN3 pseudokinase	0.101	266	237	52	317	6	270	1.036E-02	67
LOKIASV2_0914_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	0.096	264	236	45	306	126	389	7.831E-03	67
LOKIASV2_0914_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.108	256	198	55	277	8	263	7.001E-03	65
LOKIASV2_0914_ESMFold_hypothetical_protein	5ckw-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5ckw-assembly1.cif.gz_A Crystal structure of LegK4_AMPPNP Kinase	0.090	239	206	66	304	61	287	1.371E-02	63
LOKIASV2_0914_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 1	0.115	255	218	51	297	16	270	5.918E-03	62
LOKIASV2_0914_ESMFold_hypothetical_protein	6wjf-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6wjf-assembly1.cif.gz_A PKA RIIbeta holoenzyme with DnaJB1-PKAc fusion in fibrolamellar hepatoceullar carcinoma	0.125	305	245	14	294	57	361	8.759E-03	62
LOKIASV2_0914_ESMFold_hypothetical_protein	6cq4-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6cq4-assembly1.cif.gz_A TBK1 in Complex with Cyclohexyl Analog of Amlexanox	0.112	210	164	59	268	15	200	1.371E-02	62
LOKIASV2_0914_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	0.117	281	219	55	303	7	287	7.831E-03	61
LOKIASV2_0914_ESMFold_hypothetical_protein	5clr-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5clr-assembly1.cif.gz_B Crystal structure of LegK4_APO Kinase	0.098	257	230	32	287	6	262	4.730E-03	60
LOKIASV2_0914_ESMFold_hypothetical_protein	6cje-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6cje-assembly1.cif.gz_A Crystal Structure of Mnk2-D228G in complex with Inhibitor	0.104	218	191	52	269	12	225	8.707E-02	59
LOKIASV2_0914_ESMFold_hypothetical_protein	4iwq-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4iwq-assembly1.cif.gz_A Crystal structure and mechanism of activation of TBK1	0.103	206	179	59	264	16	216	1.226E-02	59
LOKIASV2_0914_ESMFold_hypothetical_protein	4im0-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4im0-assembly1.cif.gz_A-2 Structure of Tank-Binding Kinase 1	0.117	213	178	59	271	16	218	1.814E-02	58
LOKIASV2_0914_ESMFold_hypothetical_protein	6bny-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6bny-assembly1.cif.gz_A TBK1 in complex with tetrazole analog of amlexanox	0.115	184	148	59	242	14	181	3.177E-02	57
LOKIASV2_0914_ESMFold_hypothetical_protein	4im2-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4im2-assembly1.cif.gz_A Structure of Tank-Binding Kinase 1	0.113	213	179	59	271	16	218	3.360E-02	55
LOKIASV2_0914_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1	0.109	254	213	51	304	96	335	3.177E-02	53
LOKIASV2_0914_ESMFold_hypothetical_protein	4im3-assembly1.cif.gz_A-2	LOKIASV2_0914_ESMFold_hypothetical_protein	4im3-assembly1.cif.gz_A-2 Structure of Tank-Binding Kinase 1	0.118	184	138	59	242	16	173	7.360E-02	52
LOKIASV2_0914_ESMFold_hypothetical_protein	2yzl-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	2yzl-assembly1.cif.gz_A Crystal structure of phosphoribosylaminoimidazole-succinocarboxamide synthase with ADP from Methanocaldococcus jannaschii	0.117	84	64	59	142	10	83	9.153E-01	50
LOKIASV2_0914_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B Crystal structure of the Legionella pneumophila LegK7 effector kinase	0.110	303	248	21	300	134	436	3.758E-02	50
LOKIASV2_0914_ESMFold_hypothetical_protein	6nt9-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	6nt9-assembly1.cif.gz_A Cryo-EM structure of the complex between human TBK1 and chicken STING	0.118	213	164	59	271	14	200	4.973E-02	50
LOKIASV2_0914_ESMFold_hypothetical_protein	4m69-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4m69-assembly1.cif.gz_A Crystal structure of the mouse RIP3-MLKL complex	0.102	253	218	59	302	16	268	4.203E-02	49
LOKIASV2_0914_ESMFold_hypothetical_protein	6mcp-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6mcp-assembly2.cif.gz_C L. pneumophila effector kinase LegK7 (AMP-PNP bound) in complex with human MOB1A	0.121	304	245	21	300	128	431	2.401E-02	49
LOKIASV2_0914_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A Crystal structure of the Legionella pneumophila LegK7 effector kinase	0.099	316	236	21	283	130	445	1.534E-02	48
LOKIASV2_0914_ESMFold_hypothetical_protein	6mcq-assembly2.cif.gz_C	LOKIASV2_0914_ESMFold_hypothetical_protein	6mcq-assembly2.cif.gz_C L. pneumophila effector kinase LegK7 in complex with human MOB1A	0.113	384	246	22	299	128	511	3.177E-02	46
LOKIASV2_0914_ESMFold_hypothetical_protein	4ocv-assembly1.cif.gz_A	LOKIASV2_0914_ESMFold_hypothetical_protein	4ocv-assembly1.cif.gz_A N-acetylhexosamine 1-phosphate kinase_ATCC15697 in complex with GlcNAc and AMPPNP	0.078	352	238	45	303	3	354	4.702E-02	45
LOKIASV2_0914_ESMFold_hypothetical_protein	5xvj-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5xvj-assembly1.cif.gz_B Crystal structure of AL7 PAL domain	0.167	129	101	156	277	1	129	7.737E-01	30
LOKIASV2_0914_ESMFold_hypothetical_protein	4d40-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	4d40-assembly2.cif.gz_B High-Resolution Structure of a Type IV Pilin from Shewanella oneidensis	0.095	60	52	31	90	8	66	3.319E+00	27
LOKIASV2_0914_ESMFold_hypothetical_protein	1jss-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	1jss-assembly2.cif.gz_B Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4).	0.147	61	49	38	96	3	63	3.511E+00	27
LOKIASV2_0914_ESMFold_hypothetical_protein	5brl-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5brl-assembly2.cif.gz_B Crystal Structure of L124D STARD4	0.111	109	84	33	141	8	103	3.511E+00	20
LOKIASV2_0914_ESMFold_hypothetical_protein	6l1d-assembly2.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	6l1d-assembly2.cif.gz_B Structure of human StAR-related lipid transfer protein 4	0.131	60	49	40	96	6	65	8.133E+00	19
LOKIASV2_0914_ESMFold_hypothetical_protein	5ktb-assembly1.cif.gz_B	LOKIASV2_0914_ESMFold_hypothetical_protein	5ktb-assembly1.cif.gz_B Structure of a complex between S. cerevisiae Csm1 and Mam1	0.117	98	75	13	98	31	128	8.133E+00	18
